<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24447608</article-id>
      <article-id pub-id-type="pmc">3943380</article-id>
      <article-id pub-id-type="publisher-id">1746-1596-9-17</article-id>
      <article-id pub-id-type="doi">10.1186/1746-1596-9-17</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes" id="A1">
          <name>
            <surname>Li</surname>
            <given-names>Gang</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>liliangxbyt@yahoo.com.cn</email>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes" id="A2">
          <name>
            <surname>Zhang</surname>
            <given-names>Zhiguo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>zhiguofmmu@163.com</email>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes" id="A3">
          <name>
            <surname>Zhang</surname>
            <given-names>Jianghong</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>814122349@qq.com</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Jin</surname>
            <given-names>Tianbo</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>jintianbo@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Liang</surname>
            <given-names>Hongjuan</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>banyue@5460.com</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Gong</surname>
            <given-names>Li</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>82432234@qq.com</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Cui</surname>
            <given-names>Guangbin</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>cgbtd@yahoo.com.cn</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Yang</surname>
            <given-names>Haixia</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>tdhx2009@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A9">
          <name>
            <surname>He</surname>
            <given-names>Shiming</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>heshimingbrain@yahoo.com.cn</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A10">
          <name>
            <surname>Zhang</surname>
            <given-names>Yongsheng</given-names>
          </name>
          <xref ref-type="aff" rid="I5">5</xref>
          <email>zhangys_td@163.com</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A11">
          <name>
            <surname>Gao</surname>
            <given-names>Guodong</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>gguodong@fmmu.edu.cn</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi&#x2019;an 710038, P.R China</aff>
      <aff id="I2"><label>2</label>National Engineering Research Center for Miniaturized Detection Systems, School of Life Sciences, Northwest University, Xi&#x2019;an 710069, P.R China</aff>
      <aff id="I3"><label>3</label>Department of Pathology, Tangdu Hospital, Fourth Military Medical University, Xi&#x2019;an 710038, P.R China</aff>
      <aff id="I4"><label>4</label>Department of Radiology, Tangdu Hospital, Fourth Military Medical University, Xi&#x2019;an 710038, P.R China</aff>
      <aff id="I5"><label>5</label>Department of Administrative, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, P.R. China</aff>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>1</month>
        <year>2014</year>
      </pub-date>
      <volume>9</volume>
      <fpage>17</fpage>
      <lpage>17</lpage>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>12</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 Li et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Li et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.diagnosticpathology.org/content/9/1/17"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>It is generally believed that malignant gliomas never metastasize outside the central nervous system (CNS). However, the notion that oligodendrogliomas (OGDs) cells cannot spread outside CNS is being challenged.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>We described in detail the clinical story of one patient with anaplastic OGD, which metastasized to lymph nodes, bone marrowand bones Genetic analyses included detection of 1p and 19q chromosomal arms, methylation status of <italic>MGMT</italic> promoter, and <italic>PTEN</italic> exon mutations. A search of worldwide literature was conducted for reports of metastatic OGDs using NCBI-PubMed, with the keywords &#x201C;extracranial&#x201D;, &#x201C;extraneural&#x201D;, &#x201C;oligodendroglioma&#x201D;, &#x201C;oligodendrogliomas&#x201D;, &#x201C;metastatic&#x201D;, &#x201C;metastasis&#x201D;, and &#x201C;metastases&#x201D;, in different combinations.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>An open biopsy of the infiltrated bones in our patient revealed that malignant cells had replaced the patient&#x2019;s marrow. Moreover, the diagnosis of multiple-organ metastases of anaplastic OGD was confirmed based on immunohistochemical staining. Genetic analyses showed that the tumors originated from previously resected brain lesions. None of the lesions had 1p and 19q deletions, but hypermethylation of <italic>MGMT</italic> promoter, and the G &#x2192; A transversion at codon 234 of <italic>PTEN</italic> exon 2 were detected. Literatures review yielded 60 reports of metastatic OGDs from 1951 to the present, which with our patient makes 61 cases. Concerning these 61 patients, there were 110 infiltrated sites correlated closely with primary OGDs. The most frequent metastatic sites were bone and bone marrow (<italic>n</italic> = 47; 42.7%), lymph nodes (<italic>n</italic> = 22; 20.0%), liver (<italic>n</italic> = 7; 6.4%), scalp (<italic>n</italic> = 6; 5.5%), lung (<italic>n</italic> = 6; 5.5%), pleura (<italic>n</italic> = 4; 3.6%), chest wall (<italic>n</italic> = 3; 2.7%), iliopsoas muscle (<italic>n</italic> = 2; 1.8%), soft tissue (<italic>n</italic> = 2; 1.8%), and parotid gland (<italic>n</italic> = 2; 1.8%).</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Extracranial metastases in anaplastic OGD are very rare but they do occur; bone and bone marrow may be the most common sites. Detection of certain molecular markers such as deletion of 1p and 19q chromosomal arms, hypermethylation of <italic>MGMT</italic> promoter, and characteristic <italic>PTEN</italic> exon mutations may help differentiate subtypes which are more prone to extracranial metastases.</p>
        </sec>
        <sec>
          <title>Virtual slides</title>
          <p>The virtual slide(s) for this article can be found here: <ext-link ext-link-type="uri" xlink:href="http://www.diagnosticpathology.diagnomx.eu/vs/8749838611478560">http://www.diagnosticpathology.diagnomx.eu/vs/8749838611478560</ext-link>.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Oligodendroglioma</kwd>
        <kwd>Extracranial metastasis</kwd>
        <kwd>Autopsy</kwd>
        <kwd>1p/19q</kwd>
        <kwd>Chromosome deletions</kwd>
        <kwd>Genetic analysis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>It has been widely believed by neurosurgeons and neurooncologists that malignant gliomas never metastasize outside the central nervous system (CNS) [<xref ref-type="bibr" rid="B1">1</xref>]. However, this notion has gradually proved incorrect. A review of 8000 tumors involving the CNS found only 35 cases of extracranial metastasis, including one oligodendroglioma (OGD) [<xref ref-type="bibr" rid="B2">2</xref>]. Liwnicz and Rubinstein [<xref ref-type="bibr" rid="B3">3</xref>] analyzed 116 cases in the literature and found that the most common metastasizing tumor type was glioblastoma multiforme (41.4%) followed by medulloblastoma (26.7%), ependymoma (16.4%), and astrocytoma (10.3%). and OGD (5.25%) was the least common tumor type to metastasize [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>].</p>
      <p>OGD is an uncommon diffuse glial tumor of central neuroepithelial origin, accounting for ~4.2% of all primary brain tumors. It has been mostly identified in adults, with the highest incidence occurring in the fifth and sixth decades of life, although it has also been reported in children and adolescents [<xref ref-type="bibr" rid="B5">5</xref>]. Various forms of combination therapy administered as comprehensive treatment have improved the survival of patients with OGD or mixed oligoastrocytoma [<xref ref-type="bibr" rid="B6">6</xref>].</p>
      <p>Herein, we report a case of anaplastic oligodendroglioma (AO) that metastasized to multiple lymph nodes, bone marrow, and bones, including the bilateral iliac bones, the right acetabulum, and multi-vertebral bodies.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 45-year-old male who initially presented with a short history of headache and vomiting was admitted to our hospital in September 2011. No focal neurological deficit was found on admission. Magnetic resonance imaging (MRI) showed a left solid occipital tumor with mild contrast enhancing (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>A,B,C). On 15 September 2011 he underwent a left solid occipital craniotomy with gross total resection confirmed by subsequent MRI scans (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>D,E,F). The mass was yellow and friable. It was neither hemorrhagic nor necrotic. The tumor margin was ill defined. Photomicrographs of the resected tumor showed that there were higher cell densities, densely packed round cells with perinuclear haloes, microscopically round-to-oblong cells with hyperchromatism and pleomorphism (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>A-D), clusters of capillary or plexiform capillaries (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>E,F), and obvious false fence structure-shaped necrosis (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>G,H). In addition, the irregular mitosis densities were higher. A diagnosis was made of AO, WHO (World Health Organization) grade III [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. During the subsequent 6 months, he was given 4 cycles of adjuvant chemotherapy with temozolomide (TMZ; Schering, NJ), a standard regimen [<xref ref-type="bibr" rid="B9">9</xref>] of 150&#x2013;200&#xA0;mg&#x2009;&#xB7;&#x2009;m<sup>-2</sup>&#x2009;&#xB7;&#x2009;d<sup>-1</sup> for 5 days, repeated every 28 days.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Representative axial MR images with gadolinium, taken on initial admission. (A)</bold> T<sub>1</sub>-weighted MR image (T<sub>1</sub>WI); <bold>(B)</bold> Contrast-enhanced T<sub>1</sub>WI and <bold>(C)</bold> T<sub>2</sub>-weighted MR image (T<sub>2</sub>WI) showing a left occipital tumor with mild contrast enhancing; <bold>(D)</bold> at one month follow up, T<sub>1</sub>WI; <bold>(E)</bold> contrast-enhanced T<sub>1</sub>WI and <bold>(F)</bold> T<sub>2</sub>WI showing no apparent enhanced lesion; <bold>(G)</bold> 8 months later after the first surgery, T<sub>1</sub>WI; <bold>(H)</bold> contrast-enhanced T<sub>1</sub>WI and <bold>(I)</bold> T<sub>2</sub>WI showing marked enhanced mass on the cavity and recurrence; <bold>(J)</bold> 48&#xA0;h after the second surgery, T<sub>1</sub>WI; <bold>(K)</bold> contrast-enhanced T<sub>1</sub>WI, and <bold>(L)</bold> T<sub>2</sub>WI showing no apparent enhanced lesion; <bold>(M)</bold> 8 months later after combination radiotherapy and chemotherapy, T<sub>1</sub>WI; <bold>(N)</bold> contrast-enhanced T<sub>1</sub>WI and <bold>(O)</bold> T<sub>2</sub>WI showing marked enhanced mass of the wall in the posterior portion of the removal cavity and left temporal areas, and recurrence of the enhanced tumor. <bold>(P, </bold><bold>Q)</bold> 8 months later after combination radiotherapy and chemotherapy, sagittal spinal contrast-enhanced T<sub>1</sub>WI after gadolinium infusion showing high-intensity mass lesion in <bold>(P)</bold> T7, T10, and T12 vertebral bodies (arrowheads) and <bold>(Q)</bold> T12, L2, L3, L5, and S1 vertebral bodies (arrows).</p>
        </caption>
        <graphic xlink:href="1746-1596-9-17-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Representative photomicrographs of the tumor specimens.</bold> Higher cell densities (<bold>A</bold>, <bold>B</bold>; 100&#xD7;, 200&#xD7;, respectively, H &amp; E) with perinuclear haloes (<bold>C</bold>; 200&#xD7;, H &amp; E; arrows), and microscopically round-to-oblong cells with hyperchromatism and pleomorphism (<bold>D</bold>; 400&#xD7;, <bold>H &amp; E</bold>), are compatible with AO. <bold>(E, </bold><bold>F)</bold> Clusters of capillary or plexiform capillaries (arrows), and the irregular mitosis densities were higher (100&#xD7;, 200&#xD7;, respectively, <bold>H &amp; E</bold>). <bold>(G, </bold><bold>H)</bold> Obvious false fence structure (thick arrows)-shaped necrosis (slim arrows; 100&#xD7;, 200&#xD7;, respectively, <bold>H &amp; E)</bold>. <bold>(I, </bold><bold>J)</bold> After the right iliac bone marrow needle biopsy, cells in the bone marrow specimen from the patient were small and round with a thin rim of eosinophilic cytoplasm (400&#xD7;, H &amp; E).</p>
        </caption>
        <graphic xlink:href="1746-1596-9-17-2"/>
      </fig>
      <p>A repeated left occipital tumor resection was performed 8 months later (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>G-L). Pathology also showed AO WHO grade III, with similar histology. Subsequently, irradiation therapy concomitant with TMZ, 75&#xA0;mg&#x2009;&#xB7;&#x2009;m<sup>-2</sup>&#x2009;&#xB7;&#x2009;d<sup>-1</sup> for 42 days, was given and then 3 cycles of adjuvant chemotherapy with a dose-intensive regimen of TMZ [<xref ref-type="bibr" rid="B10">10</xref>] of 75&#xA0;mg&#x2009;&#xB7;&#x2009;m<sup>-2</sup>&#x2009;&#xB7;&#x2009;d<sup>-1</sup> for 21 days, repeated every 28 days. The patient experienced no significant hematological toxicity, but he came to have difficulties in understanding and remembering.</p>
      <p>In October 2012, 5 months after the final occipital resection, he presented with a 3-week history of lumbar and right hipbone pain, and was hospitalized again in November 2012. Regretfully, brain MRI showed evident progression of the intracranial lesion (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>M-O). There was a solid enhancing lesion of high signal intensity on T<sub>2</sub>-weighted MR images, and low-intensity signals in the temporal area. The new lesion was thought to be a recurrent tumor with malignant transformation (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>M-O). MR images of the spine showed diffuse patchy areas of increased signal intensity and abnormal enhancement of the T7, T10, T12, L2, L3, L5, and S1 vertebral bodies (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>P,Q).</p>
      <p>Subsequent bone scintigraphy and positron emission tomography (PET)-computed tomography (CT) scans revealed more multifocal invasion. A whole body <sup>99m</sup>Tc-methylene diphosphonate bone scan showed hyper-activity in the right iliac bone and the tenth and twelfth thoracic vertebral bodies (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>). PET-CT scans also showed multifocal invasion of the bilateral iliac bones, the right acetabulum, the right femoral neck and the C4, T7, T10, T11, T12, L2, L3, and S1 vertebral bodies (Figure&#xA0;<xref ref-type="fig" rid="F4">4</xref>A,B), the lymph nodes at the left side of the eleventh thoracic vertebral body (Figure&#xA0;<xref ref-type="fig" rid="F4">4</xref>C) and the right supraclavicular region (Figure&#xA0;<xref ref-type="fig" rid="F4">4</xref>D).</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>Representative emission computed tomography scans. (A)</bold> anterior scans, and <bold>(B)</bold> posterior scans, showed a hypermetabolically abnormal uptake at the right iliac bone (arrowheads) and T10, and T12 vertebral bodies (arrows).</p>
        </caption>
        <graphic xlink:href="1746-1596-9-17-3"/>
      </fig>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p><bold>Representative whole body PET</bold>-<bold>CT scans. (A)</bold> and <bold>(B)</bold> Multiple foci of increased 18&#xA0;F-fluoro-2-deoxyglucose (FDG) uptake at the bilateral iliac bones, C4, T7, T11, T10, T12, L2, L3, S1 vertebral bodies and the right acetabulum; <bold>(C)</bold> Focus of increased <sup>18</sup>&#x2009;F-FDG uptake at the lymph node near the left side of the T11 vertebral body (arrows); <bold>(D)</bold> Focus of increased <sup>18</sup>&#x2009;F-FDG uptake at the lymph node of the right supraclavicular region (arrows).</p>
        </caption>
        <graphic xlink:href="1746-1596-9-17-4"/>
      </fig>
      <p>A bone marrow smear of the right iliac bone showed no plasmacytoma cells (Figure&#xA0;<xref ref-type="fig" rid="F5">5</xref>). An open biopsy of the infiltrated right iliac bone revealed the replacement of the patient&#x2019;s marrow by malignant cells, which exhibited nuclear pleomorphism (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>I,J). The confirmed diagnosis of AO metastasis to bone marrow was based on immunohistochemical staining. We simultaneously reviewed and performed the tumor cell identification in the bone marrow spaces as well as in the previously primary AO in the brain. They were all strongly positive for isocitrate dehydrogenase-1 (IDH1; Figure&#xA0;<xref ref-type="fig" rid="F6">6</xref>A,B) and Ki-67, with proliferation index &gt;80% (Figure&#xA0;<xref ref-type="fig" rid="F6">6</xref>C). They were also all positive for the glial fibrillary acidic protein (GFAP) marker (Figure&#xA0;<xref ref-type="fig" rid="F6">6</xref>D), which is positive in glial, Schwannian, and ependymal tumors (all neural tumors), and for the marker oligodendrocyte transcription factor (Oligo-2; Figure&#xA0;<xref ref-type="fig" rid="F6">6</xref>E). These findings supported the CNS origin of the metastatic cells. Further findings were all negative for other pertinent immunohistochemical stains: epithelial membrane antigen (EMA), O6&#x2013; methylguanine-DNA methyltransferase (MGMT) and vimentin (Figure&#xA0;<xref ref-type="fig" rid="F6">6</xref>F,G,H, respectively). Multiple outside pathologists confirmed this diagnosis. After discussion with the patient and his family, he was admitted to the family ward and supportive care was administered until his death on 19 January 2013.</p>
      <fig id="F5" position="float">
        <label>Figure 5</label>
        <caption>
          <p><bold>Representative scans of bone marrow smear. (A, </bold><bold>B)</bold> No plasmocytoma cells were found (100&#xD7; and 1000&#xD7;, respectively).</p>
        </caption>
        <graphic xlink:href="1746-1596-9-17-5"/>
      </fig>
      <fig id="F6" position="float">
        <label>Figure 6</label>
        <caption>
          <p><bold>Representative immunochemical markers in tumor specimens. (A, </bold><bold>B)</bold> Positive reaction for IDH1 (100&#xD7;, 200&#xD7;, respectively). <bold>(C)</bold> Positive reaction for Ki-67, with proliferating index &gt;80% (200&#xD7;). <bold>(D, </bold><bold>E)</bold> Tumor cells were positive for GFAP and Oligo-2, respectively (200&#xD7;). <bold>(F, </bold><bold>G, </bold><bold>H)</bold> showed the tumor cells were negative for EMA, MGMT, and vimentin, respectively (200&#xD7;).</p>
        </caption>
        <graphic xlink:href="1746-1596-9-17-6"/>
      </fig>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec>
        <title>Tissue samples</title>
        <p>We collected and analyzed both the bone marrow from the above mentioned open biopsy and the brain tumor tissues resected in the first and second craniotomy. The Human Research Committee of the Fourth Military Medical University approved the use of human tissues, in accordance with the Approval of Research Involving Human Subjects. The patient&#x2019;s custodians provided informed written consent. All specimens were handled and made anonymous in accordance with ethical and legal standards.</p>
      </sec>
      <sec>
        <title>DNA extraction</title>
        <p>The bone marrow from the biopsy was decalcified using ultrasonic decalcification with ethylenediaminetetraacetic acid (EDTA) as described previously [<xref ref-type="bibr" rid="B11">11</xref>] and paraffin embedded. DNA was extracted from the tumor tissues as previously described [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. In brief, DNA was isolated by sodium dodecyl sulfate/proteinase K treatment, phenol&#x2013;chloroform extraction, and ethanol precipitation and then dissolved and stored in 1&#xD7; Tris-EDTA (TE) buffer. DNA concentration was measured at optical density 260 (OD<sub>260</sub>), and purity was verified by OD<sub>260</sub>/OD<sub>280</sub>&#x2009;&#x2248;&#x2009;1.8.</p>
      </sec>
      <sec>
        <title>Fluorescent in situ hybridization (FISH) assay</title>
        <p>Sections from the brain tumors and metastatic lesions were evaluated with routine hematoxylin-eosin (H &amp; E) staining. FISH assays were also performed for molecular characterization. Both the brain tumors and the metastatic lesions were analyzed to perform dual-color FISH assay as previously published [<xref ref-type="bibr" rid="B14">14</xref>]. Briefly, paired probes for 1p36/1q25-q31 and 19q13/19p12 (Abbott Molecular) were prepared [<xref ref-type="bibr" rid="B14">14</xref>]. Green and red fluorescent signals were enumerated under a Leica microscope with appropriate filters. For each hybridization, a minimum of 40 non-overlapping nuclei were assessed for numbers of green and red signals, counted separately by two individuals.</p>
      </sec>
      <sec>
        <title>MGMT promoter methylation status</title>
        <p>DNA from the tumor tissues was analyzed by performing a methylation-specific polymerase chain reaction (MS-PCR) assay, as previously published [<xref ref-type="bibr" rid="B15">15</xref>], to detect the status of the <italic>MGMT</italic> promoter.</p>
      </sec>
      <sec>
        <title>PCR single-strand conformation polymorphism (PCR-SSCP) and DNA sequencing for phosphatase and tensin homologue (PTEN) deleted on chromosome ten exons</title>
        <p>PCR&#x2013;SSCP assay was applied to elucidate the mutations in exons 1&#x2013;9 of the <italic>PTEN</italic> gene (Table&#xA0;<xref ref-type="table" rid="T1">1</xref>) [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. PCR amplification was carried out in a final volume of 25&#xA0;&#x3BC;L containing 50&#xA0;ng DNA, 2.5&#xA0;&#x3BC;L of 10&#xD7; PCR buffer, 1.5&#xA0;mmol/L MgCl<sub>2</sub>, 10 pmol/L of each primer, 2.5&#xA0;mmol/L of each dNTP, and 1 U Taq DNA polymerase. The amplification conditions were: an initial incubation at 95&#xB0;C for 8&#xA0;min; 35 cycles at 95&#xB0;C for 30&#xA0;s, 51&#x2013;57&#xB0;C for 45&#xA0;s for each primer specific to the <italic>PTEN</italic> exons (Table&#xA0;<xref ref-type="table" rid="T1">1</xref>), and 72&#xB0;C for 30&#xA0;s; with a final extension at 72&#xB0;C for 7&#xA0;min. PCR products were resolved in 2% agarose gels stained with ethidium bromide with a 100-bp DNA ladder as a standard reference, and electrophoresed for 30&#xA0;min at 100&#xA0;V.</p>
        <table-wrap position="float" id="T1">
          <label>Table 1</label>
          <caption>
            <p><bold>
<italic>PTEN </italic>
</bold><bold>primers used for single</bold>-<bold>strand conformation polymorphism</bold> (<bold>SSCP</bold>) <bold>analysis</bold></p>
          </caption>
          <table frame="hsides" rules="groups" border="1">
            <colgroup>
              <col align="left"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="left">
                  <bold>Exon</bold>
                </th>
                <th align="center">
                  <bold>Primer sequences</bold>
                </th>
                <th align="center">
                  <bold>Annealing temp</bold>
                  <bold>. (&#xB0;</bold>
                  <bold>C)</bold>
                </th>
                <th align="center">
                  <bold>Amplicon </bold>
                  <bold>(bp)</bold>
                </th>
              </tr>
            </thead>
            <tbody valign="top">
              <tr>
                <td align="left" valign="bottom">1<hr/></td>
                <td align="center" valign="bottom">F1. 5&#x2019;-TCCTCCTTTTTCTTCAGCCAC-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">56<hr/></td>
                <td align="center" valign="bottom">147<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">R1. 5&#x2019;-GAAAGGTAAAGAGGAGCAGCC-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">2<hr/></td>
                <td align="center" valign="bottom">F2. 5&#x2019;-TGCATATTTCAGATATTTCTTTCCTT-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">57<hr/></td>
                <td align="center" valign="bottom">155<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">R2. 5&#x2019;-TTTGAAATAGAAAATCAAAGCATTC-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">3<hr/></td>
                <td align="center" valign="bottom">F3. 5&#x2019;-TGTTAATGGTGGCTTTTTG-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">56<hr/></td>
                <td align="center" valign="bottom">114<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">R3. 5&#x2019;-GCAAGCATACAAATAAGAAAAC-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">4<hr/></td>
                <td align="center" valign="bottom">F4. 5&#x2019;-TTCCTAAGTGCAAAAGATAAC-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">56<hr/></td>
                <td align="center" valign="bottom">147<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">R4. 5&#x2019;-TACAGTCTATCGGGTTTAAGT-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">5<hr/></td>
                <td align="center" valign="bottom">F5. 5&#x2019;-TTTTTTTTTCTTATTCTGAGGTTATC-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">51<hr/></td>
                <td align="center" valign="bottom">312<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">R5. 5&#x2019;-GAAGAGGAAAGGAAAAACATC-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">6<hr/></td>
                <td align="center" valign="bottom">F6. 5&#x2019;-AGTGAAATAACTATAATGGAACA-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">54<hr/></td>
                <td align="center" valign="bottom">231<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">R6. 5&#x2019;-GAAGGATGAGAATTTCAAGC-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">7<hr/></td>
                <td align="center" valign="bottom">F7. 5&#x2019;-ATCGTTTTTGACAGTTTG-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">55<hr/></td>
                <td align="center" valign="bottom">262<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">R7. 5&#x2019;-TCCCAATGAAAGTAAAGTAGA-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">8<hr/></td>
                <td align="center" valign="bottom">F8. 5&#x2019;-AGGTGACAGATTTTCTTTTTTA-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">52<hr/></td>
                <td align="center" valign="bottom">394<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">R8. 5&#x2019;-TAGCTGTACTCCTAGAATTA-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
                <td align="center" valign="bottom">&#xA0;<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">9<hr/></td>
                <td align="center" valign="bottom">F9. 5&#x2019;-CTTTCTCTAGGTFAAGCTGTACTT-3&#x2019;<hr/></td>
                <td align="center" valign="bottom">55<hr/></td>
                <td align="center" valign="bottom">231<hr/></td>
              </tr>
              <tr>
                <td align="left">&#xA0;</td>
                <td align="center">R9. 5&#x2019;-TTCATGGTGTTTTATCCCTCTTGA-3&#x2019;</td>
                <td align="center">&#xA0;</td>
                <td align="center">&#xA0;</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>SSCP analyses of all <italic>PTEN</italic> exons were conducted systematically on the PCR products. Equal volumes (7&#xA0;&#x3BC;L) of the PCR products and loading buffer (95% formamide, 20&#xA0;mM EDTA, 0.05% bromphenol blue, and 0.05% xylene cyanol) were mixed and centrifuged for 15&#xA0;s, heat-denatured at 95&#xB0;C for 7&#xA0;min, snap-chilled on ice for 10&#xA0;min, and resolved through an 8% non-denaturing polyacrylamide gel (acrylamide to bisacrylamide, 29:1) containing 50&#xA0;mM Tris-borate (pH&#xA0;7.5) and 2.5&#xA0;mM EDTA, and electrophoresed with 1&#xD7; tris-borate-EDTA buffer for 16&#xA0;h at 14&#xB0;C at a voltage of 100&#xA0;V. Silver staining was performed as previously described [<xref ref-type="bibr" rid="B19">19</xref>].</p>
        <p>According to the PCR-SSCP results of genomic DNA, the present sample was considered PCR-SSCP positive based on the evident difference in the single strand strip number and electrophoresis transference location [<xref ref-type="bibr" rid="B20">20</xref>]. Genomic DNA from the positive PCR-SSCP sample was amplified again in a 40-&#x3BC;L reaction system for bidirectional DNA sequencing. The amplified PCR products were sequenced with an ABI PRISM 310 dye terminator cycle sequencing ready reaction kit. The results were compared using the GenBank database.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>FISH analysis</title>
        <p>None of the tumors from the resected brain lesions or the metastatic lesions had the 1p (Figure&#xA0;<xref ref-type="fig" rid="F7">7</xref>A) or 19q deletions (Figure&#xA0;<xref ref-type="fig" rid="F7">7</xref>B). We were satisfied that, although the bone marrow from the biopsy was decalcified via ultrasonic decalcification and EDTA, the metastatic lesions remained informative.</p>
        <fig id="F7" position="float">
          <label>Figure 7</label>
          <caption>
            <p><bold>Representative FISH images from the right iliac bone.</bold> Some signals are missing due to nuclear truncation. <bold>(A)</bold> No 1p deletion, with 2 red (1p36, arrows) and 2 green (1q25-q31, arrowheads) signals in scattered nuclei. <bold>(B)</bold> No 19q deletion with 2 red (19q13, arrows) and 2 green (19p12, arrowheads) signals in scattered nuclei.</p>
          </caption>
          <graphic xlink:href="1746-1596-9-17-7"/>
        </fig>
      </sec>
      <sec>
        <title>Methylation status of the MGMT promoter</title>
        <p>The MSP-PCR assays of the tumors from the primary brain lesions and autopsied metastasized tissues all showed the methylated <italic>MGMT</italic> promoter (Figure&#xA0;<xref ref-type="fig" rid="F8">8</xref>), and the result from the corresponding samples was nearly identical.</p>
        <fig id="F8" position="float">
          <label>Figure 8</label>
          <caption>
            <p><bold>Representative MSP</bold>-<bold>PCR for methylated </bold><bold><italic>MGMT </italic></bold><bold>promoter.</bold> NTC, non DNA template control; +, methylated; &#x2013;, unmethylated; M, DNA marker; the upper, middle, and lower bands are 140, 120, 100, and 80&#xA0;bp, respectively.</p>
          </caption>
          <graphic xlink:href="1746-1596-9-17-8"/>
        </fig>
      </sec>
      <sec>
        <title>PTEN mutation</title>
        <p>The case was considered PCR-SSCP-positive, and genomic DNA from the samples was amplified for bidirectional DNA sequencing. Compared with the sequences in the GenBank database, the sequencing data of the patient showed a transversion, &#x201C;A&#x201D; in place of &#x201C;G&#x201D; at codon 234 of exon 2. This was thought to be a likely single nucleotide polymorphism (Figure&#xA0;<xref ref-type="fig" rid="F9">9</xref>). No mutation was detected in the other <italic>PTEN</italic> exons.</p>
        <fig id="F9" position="float">
          <label>Figure 9</label>
          <caption>
            <p><bold>Representative sequencing data showing the G</bold>&#x2009;&#x2192;&#x2009;<bold>A transversion at codon 234 (arrows) of exon 2 in </bold><bold><italic>PTEN </italic></bold><bold>of the patient.</bold> Blue, primer; red, exon 2; purple, the transversion of A, showing the polymorphism.</p>
          </caption>
          <graphic xlink:href="1746-1596-9-17-9"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Extraneural metastases from primary brain tumors are rare [<xref ref-type="bibr" rid="B21">21</xref>] for reasons that remain obscure. Proposed initial theories generally lack credibility among neurosurgeons and neurooncologists; these include collapse of thin-walled cerebral veins, the inability of neural tissue to grow outside the CNS, and the lack of lymphatics in the brain [<xref ref-type="bibr" rid="B22">22</xref>]. More accepted is the theory that because brain tumors present earlier, there is less time for metastases to develop [<xref ref-type="bibr" rid="B21">21</xref>]. Another theory suggests that the intracerebral environment is not sufficiently hostile to select out metastatic clones. There is relatively little connective tissue stroma in the brain compared with the rest of the body. It has also been proposed that clones are not selected for the ability to invade fibrous connective tissue and are thus not suited to invade extracranial tissues [<xref ref-type="bibr" rid="B23">23</xref>]. The role of the blood&#x2013;brain barrier is also uncertain, albeit it does seem to have a limited role in metastasis.</p>
      <p>Despite the above theories, glioma does metastasize outside the CNS, and most cases of extraneural metastasis (nearly 96%) have occurred after surgical excision of the primary tumor [<xref ref-type="bibr" rid="B24">24</xref>]. The most common glioma to metastasize is glioblastoma multiforme, followed by medulloblastoma and ependymoma [<xref ref-type="bibr" rid="B4">4</xref>], while OGD metastasizes very rarely.</p>
      <p>OGD is such a diffuse glial tumor. Extracranial metastasis of the primary intracranial neoplasm is infrequent generally, and it seemed to usually happen only in the setting of prior neurosurgical resection [<xref ref-type="bibr" rid="B25">25</xref>]. OGDs are characterized by multiple recurrences [<xref ref-type="bibr" rid="B25">25</xref>], extraneural spread is unusual, and distant skeletal metastases are particularly infrequent. We therefore undertook a worldwide literature review to investigate further the incidence of extraneural metastases. This yielded 60 previously reported metastatic OGDs from 1951 to the present, and our patient makes 61 (Table&#xA0;<xref ref-type="table" rid="T2">2</xref>). The review was performed using NCBI-PubMed with the keywords &#x201C;extracranial&#x201D;, &#x201C;extraneural&#x201D;, &#x201C;oligodendroglioma&#x201D;, &#x201C;oligodendrogliomas&#x201D;, &#x201C;metastatic&#x201D;, &#x201C;metastasis&#x201D;, and &#x201C;metastases&#x201D; in different combinations. We also reviewed the bibliography of the subsequently selected articles.</p>
      <table-wrap position="float" id="T2">
        <label>Table 2</label>
        <caption>
          <p>Review from the literature of 61 reported patients with oligodendroglioma with metastases outside the CNS</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">
                <bold>Patient no.</bold>
              </th>
              <th align="left">
                <bold>Gender</bold>
              </th>
              <th align="left">
                <bold>Subjects</bold>
              </th>
              <th align="left">
                <bold>WHO grade</bold>
              </th>
              <th align="left">
                <bold>Age at diagnosis </bold>
                <bold>(y)</bold>
              </th>
              <th align="left">
                <bold>Location of metastasis</bold>
              </th>
              <th align="left">
                <bold>OS </bold>
                <bold>(months)</bold>
              </th>
              <th align="left">
                <bold>Time between presentation of primary tumor and metastasis </bold>
                <bold>(months)</bold>
              </th>
              <th align="left">
                <bold>Molecular biomarkers tested</bold>
              </th>
              <th align="left">
                <bold>Reference</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">1<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">British<hr/></td>
              <td align="left" valign="bottom">ODG, low grade early, later *AO<hr/></td>
              <td align="left" valign="bottom">25<hr/></td>
              <td align="left" valign="bottom">Cervical lymph nodes, scalp, lung, bone<hr/></td>
              <td align="left" valign="bottom">84<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">James et al. 1951 [<xref ref-type="bibr" rid="B26">26</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">2<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">American<hr/></td>
              <td align="left" valign="bottom">ODG, *grade<hr/></td>
              <td align="left" valign="bottom">7<hr/></td>
              <td align="left" valign="bottom">Scalp, bone, soft tissue, liver<hr/></td>
              <td align="left" valign="bottom">36<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Spataro et al. 1968 [<xref ref-type="bibr" rid="B27">27</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">3<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Austrian<hr/></td>
              <td align="left" valign="bottom">ODG, *grade<hr/></td>
              <td align="left" valign="bottom">58<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">30<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Jellinger et al. 1969 [<xref ref-type="bibr" rid="B28">28</xref>], (also reported as Schuster et al. 1976 [<xref ref-type="bibr" rid="B29">29</xref>])<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">4<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">American<hr/></td>
              <td align="left" valign="bottom">*ODG, *grade<hr/></td>
              <td align="left" valign="bottom">45<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">17<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Smith et al. 1969 [<xref ref-type="bibr" rid="B2">2</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">5<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">ODG, initially low grade<hr/></td>
              <td align="left" valign="bottom">3.5<hr/></td>
              <td align="left" valign="bottom">Lymph nodes, lungs, adrenal<hr/></td>
              <td align="left" valign="bottom">21<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Kernohan 1971 [<xref ref-type="bibr" rid="B30">30</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">6<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Scottish<hr/></td>
              <td align="left" valign="bottom">Malignant glioma, some ODG features<hr/></td>
              <td align="left" valign="bottom">21<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">9<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Eade et al. 1971 [<xref ref-type="bibr" rid="B31">31</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">7<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Scottish<hr/></td>
              <td align="left" valign="bottom">Small cell GBM with regions of ODG<hr/></td>
              <td align="left" valign="bottom">23<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">12<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">8<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">French<hr/></td>
              <td align="left" valign="bottom">*ODG, *grade<hr/></td>
              <td align="left" valign="bottom">57<hr/></td>
              <td align="left" valign="bottom">Lymph nodes, bone<hr/></td>
              <td align="left" valign="bottom">20<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Cappellaere et al. 1972 [<xref ref-type="bibr" rid="B32">32</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">9<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">French<hr/></td>
              <td align="left" valign="bottom">*ODG, *grade<hr/></td>
              <td align="left" valign="bottom">22<hr/></td>
              <td align="left" valign="bottom">Lymph nodes, bone, parotid gland<hr/></td>
              <td align="left" valign="bottom">25<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">10<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">British<hr/></td>
              <td align="left" valign="bottom">Malignant glioma, some ODG features<hr/></td>
              <td align="left" valign="bottom">30<hr/></td>
              <td align="left" valign="bottom">Pleura<hr/></td>
              <td align="left" valign="bottom">156<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Brander et al. 1975 [<xref ref-type="bibr" rid="B33">33</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">11<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">German<hr/></td>
              <td align="left" valign="bottom">*ODG, *grade<hr/></td>
              <td align="left" valign="bottom">40<hr/></td>
              <td align="left" valign="bottom">Bone, lymph nodes, lungs<hr/></td>
              <td align="left" valign="bottom">86<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Kummer et al. 1977 [<xref ref-type="bibr" rid="B34">34</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">12<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Canadian<hr/></td>
              <td align="left" valign="bottom">*ODG, *grade<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Scalp<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Chin et al. 1980 [<xref ref-type="bibr" rid="B35">35</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">13<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">American<hr/></td>
              <td align="left" valign="bottom">ODG, grade II<hr/></td>
              <td align="left" valign="bottom">33<hr/></td>
              <td align="left" valign="bottom">Bone, lymph nodes, scalp, soft tissue<hr/></td>
              <td align="left" valign="bottom">50<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Ordonez et al. 1981 [<xref ref-type="bibr" rid="B36">36</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">14<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Japanese<hr/></td>
              <td align="left" valign="bottom">Grade III<hr/></td>
              <td align="left" valign="bottom">32<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">76<hr/></td>
              <td align="left" valign="bottom">14<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Nakamura et al. 1985 [<xref ref-type="bibr" rid="B37">37</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">15<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">ODG, malignant<hr/></td>
              <td align="left" valign="bottom">41<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">48<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Newman et al. 1985 [<xref ref-type="bibr" rid="B38">38</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">16<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Canadian<hr/></td>
              <td align="left" valign="bottom">ODG, *grade, some astro<hr/></td>
              <td align="left" valign="bottom">12<hr/></td>
              <td align="left" valign="bottom">Bone, lymph nodes, scalp<hr/></td>
              <td align="left" valign="bottom">104<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Macdonald et al. 1989 [<xref ref-type="bibr" rid="B39">39</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">17<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Canadian<hr/></td>
              <td align="left" valign="bottom">ODG, *grade<hr/></td>
              <td align="left" valign="bottom">44<hr/></td>
              <td align="left" valign="bottom">Cervical lymph nodes, bone,<hr/></td>
              <td align="left" valign="bottom">48<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">18<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Canadian<hr/></td>
              <td align="left" valign="bottom">ODG, grade III<hr/></td>
              <td align="left" valign="bottom">36<hr/></td>
              <td align="left" valign="bottom">Bone, lymph nodes<hr/></td>
              <td align="left" valign="bottom">60<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">19<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Canadian<hr/></td>
              <td align="left" valign="bottom">ODG, *grade, some astro<hr/></td>
              <td align="left" valign="bottom">32<hr/></td>
              <td align="left" valign="bottom">Bone, lymph nodes, scalp<hr/></td>
              <td align="left" valign="bottom">38<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">20<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Canadian<hr/></td>
              <td align="left" valign="bottom">ODG, *grade<hr/></td>
              <td align="left" valign="bottom">34<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">76+<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">21<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Canadian<hr/></td>
              <td align="left" valign="bottom">ODG, grade III<hr/></td>
              <td align="left" valign="bottom">27<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">37<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">22<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Canadian<hr/></td>
              <td align="left" valign="bottom">ODG, *grade, some astro<hr/></td>
              <td align="left" valign="bottom">47<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">26+<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">23<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Polish<hr/></td>
              <td align="left" valign="bottom">Grade III<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Rolski et al. 1993 [<xref ref-type="bibr" rid="B40">40</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">24<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">German<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Cervical lymph nodes<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Steininger et al. 1993 [<xref ref-type="bibr" rid="B41">41</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">25<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">British<hr/></td>
              <td align="left" valign="bottom">ODG, grade III<hr/></td>
              <td align="left" valign="bottom">54<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">12<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Gerrard et al. 1995 [<xref ref-type="bibr" rid="B42">42</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">26<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">German<hr/></td>
              <td align="left" valign="bottom">Grade III<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Cervical lymph nodes<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">48<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Schroder et al. 1995 [<xref ref-type="bibr" rid="B43">43</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">27<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Italian<hr/></td>
              <td align="left" valign="bottom">ODG, grade II<hr/></td>
              <td align="left" valign="bottom">58<hr/></td>
              <td align="left" valign="bottom">Chest wall, bone marrow, possibly liver<hr/></td>
              <td align="left" valign="bottom">48<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Monzani et al. 1996 [<xref ref-type="bibr" rid="B44">44</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">28<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">British<hr/></td>
              <td align="left" valign="bottom">ODG, grade III<hr/></td>
              <td align="left" valign="bottom">43<hr/></td>
              <td align="left" valign="bottom">Bone marrow, liver<hr/></td>
              <td align="left" valign="bottom">3<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Dawson 1997 [<xref ref-type="bibr" rid="B45">45</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">29<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Austrian<hr/></td>
              <td align="left" valign="bottom">ODG-astrocytoma grade III<hr/></td>
              <td align="left" valign="bottom">62<hr/></td>
              <td align="left" valign="bottom">Thoracic wall, pleura, bone marrow<hr/></td>
              <td align="left" valign="bottom">288<hr/></td>
              <td align="left" valign="bottom">6<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Finsterer et al. 1998 [<xref ref-type="bibr" rid="B46">46</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">30<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Indian<hr/></td>
              <td align="left" valign="bottom">Grade III<hr/></td>
              <td align="left" valign="bottom">50<hr/></td>
              <td align="left" valign="bottom">Bone and bone marrow<hr/></td>
              <td align="left" valign="bottom">7+<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Anand et al. 2001 [<xref ref-type="bibr" rid="B47">47</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">31<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Italian<hr/></td>
              <td align="left" valign="bottom">ODG, grade II<hr/></td>
              <td align="left" valign="bottom">25<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">84+<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Giordana et al. 2002 [<xref ref-type="bibr" rid="B48">48</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">32<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Indian<hr/></td>
              <td align="left" valign="bottom">Grade III<hr/></td>
              <td align="left" valign="bottom">50<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">17<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Sharma et al. 2003 [<xref ref-type="bibr" rid="B49">49</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">33<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">American<hr/></td>
              <td align="left" valign="bottom">Grade III<hr/></td>
              <td align="left" valign="bottom">33<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">38+<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Choon et al. 2004 [<xref ref-type="bibr" rid="B50">50</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">34<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Canadian<hr/></td>
              <td align="left" valign="bottom">Grade III<hr/></td>
              <td align="left" valign="bottom">35<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">84<hr/></td>
              <td align="left" valign="bottom">23<hr/></td>
              <td align="left" valign="bottom">Allelic LOH of chromosome 1p (1p-), a rise in serum alkaline phosphatase<hr/></td>
              <td align="left" valign="bottom">Morrison et al. 2004 [<xref ref-type="bibr" rid="B51">51</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">35<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">American<hr/></td>
              <td align="left" valign="bottom">ODG, grade II early, later AO, grade III<hr/></td>
              <td align="left" valign="bottom">41<hr/></td>
              <td align="left" valign="bottom">Parotid gland<hr/></td>
              <td align="left" valign="bottom">79+<hr/></td>
              <td align="left" valign="bottom">68<hr/></td>
              <td align="left" valign="bottom">Codeletion of 1p/19q<hr/></td>
              <td align="left" valign="bottom">Wang et al. 2004 [<xref ref-type="bibr" rid="B52">52</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">36<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">American<hr/></td>
              <td align="left" valign="bottom">ODG, low grade early, later AO, grade III<hr/></td>
              <td align="left" valign="bottom">28<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">120<hr/></td>
              <td align="left" valign="bottom">5<hr/></td>
              <td align="left" valign="bottom">Positive for S-100 marker with immunohistochemical stain<hr/></td>
              <td align="left" valign="bottom">Al-Ali et al. 2005 [<xref ref-type="bibr" rid="B23">23</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">37<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">American<hr/></td>
              <td align="left" valign="bottom">Atypical meningioma, early, later AO, grade III<hr/></td>
              <td align="left" valign="bottom">32<hr/></td>
              <td align="left" valign="bottom">Bone, bone marrow, cervical and thoracic lesions<hr/></td>
              <td align="left" valign="bottom">168<hr/></td>
              <td align="left" valign="bottom">27<hr/></td>
              <td align="left" valign="bottom">Elevated serum lactate dehydrogenase and alkaline phosphatase, positive for S-100, and GFAP with immunohistochemical stain<hr/></td>
              <td align="left" valign="bottom">Merrell et al. 2006 [<xref ref-type="bibr" rid="B53">53</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">38<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">American<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">71<hr/></td>
              <td align="left" valign="bottom">Bone, bone marrow,<hr/></td>
              <td align="left" valign="bottom">17<hr/></td>
              <td align="left" valign="bottom">13<hr/></td>
              <td align="left" valign="bottom">Codeletion of 1p/19q, positive for S-100, and GFAP with immunohistochemical stain, elevated serum hemoglobin level<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">39<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Chinese<hr/></td>
              <td align="left" valign="bottom">ODG, *grade<hr/></td>
              <td align="left" valign="bottom">64<hr/></td>
              <td align="left" valign="bottom">Pleura, bone<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">84<hr/></td>
              <td align="left" valign="bottom">Positive for S-100, Olig2 and GFAP with immunohistochemical stain<hr/></td>
              <td align="left" valign="bottom">Lee et al. 2006 [<xref ref-type="bibr" rid="B54">54</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">40<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">American<hr/></td>
              <td align="left" valign="bottom">ODG, grade II early, later AO, grade III<hr/></td>
              <td align="left" valign="bottom">15<hr/></td>
              <td align="left" valign="bottom">Pleura, bone, lungs, adrenal gland, chest, liver, abdomen<hr/></td>
              <td align="left" valign="bottom">62<hr/></td>
              <td align="left" valign="bottom">31<hr/></td>
              <td align="left" valign="bottom">Codeletion of 1p/19q<hr/></td>
              <td align="left" valign="bottom">Bruggers et al. 2007 [<xref ref-type="bibr" rid="B55">55</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">41<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Japanese<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">17<hr/></td>
              <td align="left" valign="bottom">Spleen, liver, pancreas, bone, spinal dura mater, dorsal root ganglia, lungs, lymph nodes, iliopsoas muscle<hr/></td>
              <td align="left" valign="bottom">144<hr/></td>
              <td align="left" valign="bottom">3<hr/></td>
              <td align="left" valign="bottom">Markedly positive for Ki-67, and positive for Olig2 with immunohistochemical stain,<hr/></td>
              <td align="left" valign="bottom">Uzuka et al. 2007 [<xref ref-type="bibr" rid="B56">56</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">42<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Korean<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">48<hr/></td>
              <td align="left" valign="bottom">Liver, lungs<hr/></td>
              <td align="left" valign="bottom">28<hr/></td>
              <td align="left" valign="bottom">27<hr/></td>
              <td align="left" valign="bottom">Not presented<hr/></td>
              <td align="left" valign="bottom">Han et al. 2008 [<xref ref-type="bibr" rid="B4">4</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">43<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Italian<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">40<hr/></td>
              <td align="left" valign="bottom">Bone, bone marrow, liver<hr/></td>
              <td align="left" valign="bottom">10<hr/></td>
              <td align="left" valign="bottom">5<hr/></td>
              <td align="left" valign="bottom">Not presented<hr/></td>
              <td align="left" valign="bottom">Zustovich et al. 2008 [<xref ref-type="bibr" rid="B57">57</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">44<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Slovenian<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">54<hr/></td>
              <td align="left" valign="bottom">Cervical and neck lymph nodes<hr/></td>
              <td align="left" valign="bottom">48<hr/></td>
              <td align="left" valign="bottom">12<hr/></td>
              <td align="left" valign="bottom">Positive for S-100, and GFAP with immunohistochemical stain<hr/></td>
              <td align="left" valign="bottom">Volavsek et al. 2009 [<xref ref-type="bibr" rid="B58">58</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">45<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Slovenian<hr/></td>
              <td align="left" valign="bottom">AOA, grade III<hr/></td>
              <td align="left" valign="bottom">30<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">58+<hr/></td>
              <td align="left" valign="bottom">17<hr/></td>
              <td align="left" valign="bottom">Positive for GFAP with immunohistochemical stain<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">46<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Japanese<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">53<hr/></td>
              <td align="left" valign="bottom">Lymph nodes, bone, spinal dura mater, thymus gland, chest wall<hr/></td>
              <td align="left" valign="bottom">30<hr/></td>
              <td align="left" valign="bottom">24<hr/></td>
              <td align="left" valign="bottom">Codeletion of 1p/19q<hr/></td>
              <td align="left" valign="bottom">Noshita N, et al. 2010 [<xref ref-type="bibr" rid="B59">59</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">47<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Japanese<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">73<hr/></td>
              <td align="left" valign="bottom">Cervical lesion<hr/></td>
              <td align="left" valign="bottom">18+<hr/></td>
              <td align="left" valign="bottom">18<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Oshiro S, et al. 2010 [<xref ref-type="bibr" rid="B60">60</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">48<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Dutch<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">59<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">33<hr/></td>
              <td align="left" valign="bottom">31<hr/></td>
              <td align="left" valign="bottom">Codeletion of 1p/19q, positive for S-100, and p53 with immunohistochemical stain<hr/></td>
              <td align="left" valign="bottom">Krijnen JL, et al. 2010 [<xref ref-type="bibr" rid="B61">61</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">49<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Dutch<hr/></td>
              <td align="left" valign="bottom">*ODG, *grade<hr/></td>
              <td align="left" valign="bottom">24<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">84<hr/></td>
              <td align="left" valign="bottom">Not presented<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">50<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Dutch<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">34<hr/></td>
              <td align="left" valign="bottom">Cervical lymph nodes, iliopsoas muscle<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">not presented<hr/></td>
              <td align="left" valign="bottom">Not presented<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">51<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Dutch<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">64<hr/></td>
              <td align="left" valign="bottom">Axillary lymph nodes<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">34<hr/></td>
              <td align="left" valign="bottom">Not presented<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">52<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Dutch<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">72<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">6<hr/></td>
              <td align="left" valign="bottom">Not presented<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">53<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Dutch<hr/></td>
              <td align="left" valign="bottom">*ODG, *grade<hr/></td>
              <td align="left" valign="bottom">67<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">29<hr/></td>
              <td align="left" valign="bottom">Not presented<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">54<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Dutch<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">62<hr/></td>
              <td align="left" valign="bottom">Retroperitoneal lymph nodes<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">21<hr/></td>
              <td align="left" valign="bottom">Not presented<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">55<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Turkish<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">55<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">23+<hr/></td>
              <td align="left" valign="bottom">11<hr/></td>
              <td align="left" valign="bottom">Positive for GFAP with immunohistochemical stain<hr/></td>
              <td align="left" valign="bottom">Kural C, et al. 2011 [<xref ref-type="bibr" rid="B62">62</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">56<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Chinese<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">37<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">58+<hr/></td>
              <td align="left" valign="bottom">37<hr/></td>
              <td align="left" valign="bottom">Positive for S-100, and GFAP with immunohistochemical stain<hr/></td>
              <td align="left" valign="bottom">Wu Y, et al. 2011 [<xref ref-type="bibr" rid="B63">63</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">57<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Italian<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">40<hr/></td>
              <td align="left" valign="bottom">Bone marrow<hr/></td>
              <td align="left" valign="bottom">61<hr/></td>
              <td align="left" valign="bottom">57<hr/></td>
              <td align="left" valign="bottom">Positive for enolase, and GFAP with immunohistochemical stain<hr/></td>
              <td align="left" valign="bottom">Cordiano V, et al. 2012 [<xref ref-type="bibr" rid="B64">64</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">58<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Turkish<hr/></td>
              <td align="left" valign="bottom">ODG, *grade<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Cervical lymphatic chain<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">60<hr/></td>
              <td align="left" valign="bottom">Codeletion of 1p/19q<hr/></td>
              <td align="left" valign="bottom">Can B, et al. 2012 [<xref ref-type="bibr" rid="B65">65</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">59<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Turkish<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">58<hr/></td>
              <td align="left" valign="bottom">Breast<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">*<hr/></td>
              <td align="left" valign="bottom">Alacacioglu A, et al. 2012 [<xref ref-type="bibr" rid="B66">66</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">60<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Irish<hr/></td>
              <td align="left" valign="bottom">AO, grade III<hr/></td>
              <td align="left" valign="bottom">58<hr/></td>
              <td align="left" valign="bottom">Bone<hr/></td>
              <td align="left" valign="bottom">120+<hr/></td>
              <td align="left" valign="bottom">108<hr/></td>
              <td align="left" valign="bottom">Codeletion of 1p/19q, positive for GFAP with immunohistochemical stain<hr/></td>
              <td align="left" valign="bottom">Greene J, et al. 2013 [<xref ref-type="bibr" rid="B67">67</xref>]<hr/></td>
            </tr>
            <tr>
              <td align="left">61</td>
              <td align="left">M</td>
              <td align="left">Chinese</td>
              <td align="left">AO, grade III</td>
              <td align="left">45</td>
              <td align="left">Bone, bone marrow, lymph nodes</td>
              <td align="left">16</td>
              <td align="left">13</td>
              <td align="left">No deletion of 1p/ 19q, <italic>PTEN</italic> mutation in exon 2, <italic>MGMT</italic> promoter methylated, positive for IDH1, Ki-67, Olig2, and GFAP, negative for MGMT, EMA and Vim with immunohistochemical stain</td>
              <td align="left">Present case</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>F: <italic>f</italic>emale, <italic>M</italic>: male, <italic>OS</italic>: overall survival, <italic>WHO</italic>: World Health Organization, <italic>LOH</italic>: loss of heterozygosity, <italic>ODG</italic>: oligodendroglioma, <italic>AO</italic>: anaplastic oligodendroglioma, <italic>AOA</italic>: anaplastic oligoastrocytoma, <italic>GBM</italic>: glioblastoma multiforme.</p>
          <p>*Not provided in the corresponding literature.</p>
          <p>+ alive at publication.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>Of the 61 reported metastatic OGDs, 33 (54.1%) were male, 17 (27.9%) were female, and in the remaining cases 18.0% gender was not reported (Table&#xA0;<xref ref-type="table" rid="T3">3</xref>). Ten (16.4%) patients were Asian, 30 (49.2%) were European, 18 (29.5%) were American or Canadian, and for the remaining 3 (4.9%) the ethnicities were unreported. There were 110 infiltrated sites correlated closely with primary OGDs. The most frequent metastatic site was bone and bone marrow (<italic>n</italic>&#x2009;=&#x2009;47; 42.7%) followed by lymph nodes (<italic>n</italic>&#x2009;=&#x2009;22; 20.0%), liver (<italic>n</italic>&#x2009;=&#x2009;7; 6.4%), scalp (<italic>n</italic>&#x2009;=&#x2009;6; 5.5%), lung (<italic>n</italic>&#x2009;=&#x2009;6; 5.5%), pleura (<italic>n</italic>&#x2009;=&#x2009;4; 3.6%), chest wall (<italic>n</italic>&#x2009;=&#x2009;3; 2.7%), iliopsoas muscle (<italic>n</italic>&#x2009;=&#x2009;2; 1.8%), soft tissue (<italic>n</italic>&#x2009;=&#x2009;2; 1.8%), parotid gland (<italic>n</italic>&#x2009;=&#x2009;2; 1.8%), and adrenal gland, spleen, thoracic wall, pancreas, dorsal root ganglia, abdomen, spinal dura mater, breast, and thymus gland with one lesion each (<italic>n</italic>&#x2009;=&#x2009;1; 0.9%).</p>
      <table-wrap position="float" id="T3">
        <label>Table 3</label>
        <caption>
          <p>Clinical features of 61 patients with extracranial metastatic oligodendrogliomas</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">&#xA0;</th>
              <th align="left">
                <bold>Cases</bold>
              </th>
              <th align="left">
                <bold>Rate</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td colspan="3" align="left" valign="bottom">Gender<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Total<hr/></td>
              <td align="left" valign="bottom">61<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Male<hr/></td>
              <td align="left" valign="bottom">33<hr/></td>
              <td align="left" valign="bottom">54.1% (33/61)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Female<hr/></td>
              <td align="left" valign="bottom">17<hr/></td>
              <td align="left" valign="bottom">27.9% (16/61)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Not given<hr/></td>
              <td align="left" valign="bottom">11<hr/></td>
              <td align="left" valign="bottom">18.0% (11/61)<hr/></td>
            </tr>
            <tr>
              <td colspan="3" align="left" valign="bottom">Subjects<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Total<hr/></td>
              <td align="left" valign="bottom">61<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Asian<hr/></td>
              <td align="left" valign="bottom">10<hr/></td>
              <td align="left" valign="bottom">16.4% (10/61)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">European<hr/></td>
              <td align="left" valign="bottom">30<hr/></td>
              <td align="left" valign="bottom">49.2% (30/61)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">American &amp; Canadian<hr/></td>
              <td align="left" valign="bottom">18<hr/></td>
              <td align="left" valign="bottom">29.5% (18/61)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Not given<hr/></td>
              <td align="left" valign="bottom">3<hr/></td>
              <td align="left" valign="bottom">4.9% (3/61)<hr/></td>
            </tr>
            <tr>
              <td colspan="3" align="left" valign="bottom">Location of metastasis<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Total Sites<hr/></td>
              <td align="left" valign="bottom">110<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Bone/bone marrow<hr/></td>
              <td align="left" valign="bottom">47<hr/></td>
              <td align="left" valign="bottom">42.7% (47/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Lymph node<hr/></td>
              <td align="left" valign="bottom">22<hr/></td>
              <td align="left" valign="bottom">20.0% (22/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Liver<hr/></td>
              <td align="left" valign="bottom">7<hr/></td>
              <td align="left" valign="bottom">6.4% (7/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Scalp<hr/></td>
              <td align="left" valign="bottom">6<hr/></td>
              <td align="left" valign="bottom">5.5% (6/ 110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Lung<hr/></td>
              <td align="left" valign="bottom">6<hr/></td>
              <td align="left" valign="bottom">5.5% (6/ 110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Pleura<hr/></td>
              <td align="left" valign="bottom">4<hr/></td>
              <td align="left" valign="bottom">3.6% (4/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Chest wall<hr/></td>
              <td align="left" valign="bottom">3<hr/></td>
              <td align="left" valign="bottom">2.7% (3/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Iliopsoas muscle<hr/></td>
              <td align="left" valign="bottom">2<hr/></td>
              <td align="left" valign="bottom">1.8% (2/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Soft tissue<hr/></td>
              <td align="left" valign="bottom">2<hr/></td>
              <td align="left" valign="bottom">1.8% (2/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Parotid gland<hr/></td>
              <td align="left" valign="bottom">2<hr/></td>
              <td align="left" valign="bottom">1.8% (2/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Other<hr/></td>
              <td align="left" valign="bottom">9<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Adrenal<hr/></td>
              <td align="left" valign="bottom">1<hr/></td>
              <td align="left" valign="bottom">0.9% (1/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Spleen<hr/></td>
              <td align="left" valign="bottom">1<hr/></td>
              <td align="left" valign="bottom">0.9% (1/109)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Thoracic wall<hr/></td>
              <td align="left" valign="bottom">1<hr/></td>
              <td align="left" valign="bottom">0.9% (1/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Pancreas<hr/></td>
              <td align="left" valign="bottom">1<hr/></td>
              <td align="left" valign="bottom">0.9% (1/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Dorsal root ganglia<hr/></td>
              <td align="left" valign="bottom">1<hr/></td>
              <td align="left" valign="bottom">0.9% (1/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Abdomen<hr/></td>
              <td align="left" valign="bottom">1<hr/></td>
              <td align="left" valign="bottom">0.9% (1/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Spinal dura mater<hr/></td>
              <td align="left" valign="bottom">1<hr/></td>
              <td align="left" valign="bottom">0.9% (1/110)<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Breast<hr/></td>
              <td align="left" valign="bottom">1<hr/></td>
              <td align="left" valign="bottom">0.9% (1/110)<hr/></td>
            </tr>
            <tr>
              <td align="left">Thymus gland</td>
              <td align="left">1</td>
              <td align="left">0.9% (1/109)</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>The review indicated that bone and bone marrow are the most common sites metastasizing from OGDs. In our present case, systematic examination found multiple extracranial metastases, including the vertebrae, lymph nodes, bilateral iliac bones, and right acetabulum. Metastases in these sites suggest that tumor cells were delivered via the blood vessels and lymphatic system.</p>
      <p>Primary neoplasm in the brain is generally considered to spread in any of three ways: seeding through the cerebral fluid pathway, local invasion, or spreading remotely through lymphatic and blood vessels [<xref ref-type="bibr" rid="B68">68</xref>]. It is widely accepted that the brain and spinal cord contain no lymphatic pathway. However, as the tumor cells infiltrate the dura mater, extracranial metastasis by way of the lymphatic system becomes possible, and could especially happen after craniotomy. Surgical procedures can elevate the risk of metastasis outside the nervous system by way of the lymphatic system as well as the blood vessel.</p>
      <p>Extraneural metastasis is considered correlated with multiple craniotomies, shunt surgery, and long-term survival [<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B69">69</xref>,<xref ref-type="bibr" rid="B70">70</xref>]. Extracranial metastasis without previous surgical intervention is infrequent; among 282 reported cases of glioma with metastases outside the CNS only 24 (8.5%) were spontaneous [<xref ref-type="bibr" rid="B71">71</xref>]. Most cases of extracranial metastasis occur after craniotomy. Shunt surgery is responsible for seeding tumor cells by way of cerebrospinal fluid to outside spaces [<xref ref-type="bibr" rid="B72">72</xref>]. Prolonged survival might also raise the risk of extracranial metastases. Thus, in our present case, craniotomy could be considered an influencing factor in extracranial metastasis.</p>
      <p>The median age of the 60 patients found through the literature review was 40.0&#xA0;years (range 3.5-73.0 y; Table&#xA0;<xref ref-type="table" rid="T2">2</xref>). The overall survival ranged from 3&#x2013;288&#xA0;months, with a median of 38 months. These data are consistent with the recent reports of AOs [<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B63">63</xref>]. The survival time of our patient was relatively shorter than the median, although he was given the standard regimen recommended by the National Comprehensive Cancer Net (NCCN) guidelines [<xref ref-type="bibr" rid="B73">73</xref>]. His shorter survival and poor prognosis may be due, firstly, to the presence of 1p/19q, which may have adversely influenced the success of the recommended comprehensive therapy, as combined deletion of the 1p and 19q chromosomal arms is expected in OGD [<xref ref-type="bibr" rid="B74">74</xref>]. Molecular studies have revealed that deletions of chromosome 1p and 19q are usually associated with longer survival in OGD, as well as a better response to irradiation and chemotherapy. Tumors with such a co-deletion are sensitive to comprehensive therapy, with 90-100% of patients responding [<xref ref-type="bibr" rid="B74">74</xref>,<xref ref-type="bibr" rid="B75">75</xref>]. The overall survival for AOs is about 2&#x2013;3&#xA0;years for those without the 1p/19q codeletion, compared with 6&#x2013;7&#xA0;years in those with 1p/19q loss [<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B77">77</xref>]. For our patient, the previously resected tumors from the brain lesions, as well as the metastatic lesions, all had complete 1p and 19q chromosomes. Thus the lack of deletion of 1p/19q may have led to a shorter survival time under comprehensive therapy.</p>
      <p>A second contributing factor toward the poor prognosis of the present case is the presence of the <italic>PTEN</italic> mutation, which was shown in both brain lesions and extracranial metastases. This may have made the patient more prone to extracranial metastases. <italic>PTEN</italic> tumor suppressors are located on human chromosome 10q23.3, which contains nine exons and encodes a 47-kD dual-specific protein phospholipid phosphatase with 403 amino acids [<xref ref-type="bibr" rid="B17">17</xref>]. <italic>PTEN</italic> mutations accompany nearly 50% of the cases with a 10q deletion, suggesting that there might be another progression-related target gene in this region [<xref ref-type="bibr" rid="B78">78</xref>]. <italic>PTEN</italic> mutations and 10q deletions are more common in AOs without 1p and 19q losses [<xref ref-type="bibr" rid="B79">79</xref>]. Infrequently AOs carry activating mutations in the PIK3CA gene [<xref ref-type="bibr" rid="B80">80</xref>]. <italic>PTEN</italic> mutations have also been studied for their involvement in the pathogenesis of a number of human malignancies, including glioma [<xref ref-type="bibr" rid="B80">80</xref>].</p>
      <p>Different mutations in the <italic>PTEN</italic> locus, including frameshifts and missense mutations, have proved to be correlated with human cancers [<xref ref-type="bibr" rid="B81">81</xref>,<xref ref-type="bibr" rid="B82">82</xref>]. These could result in early termination of translation and immature gene products, and subsequently lead to complete loss of vigor. In most cases, mutations in <italic>PTEN</italic> were found to decrease phosphatase activity [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B83">83</xref>]. In the present study, our patient definitely had a substitution mutation in <italic>PTEN</italic> at exon 2, which may have made him more prone to extracranial metastases.</p>
      <p>It must also be noted that, although our patient underwent a chemotherapy regimen with TMZ, his condition nevertheless deteriorated more rapidly afterward. As known, AOs are chemosensitive neoplasms that respond to combined treatment with lomustine, vincristine and procarbazine (i.e., PCV therapy), with 60-70% of patients responding [<xref ref-type="bibr" rid="B84">84</xref>]. Studies have also shown that TMZ, the oral alkylating agent that inhibits DNA replication by methylating nucleotide bases, is active and particularly well tolerated in AO patients [<xref ref-type="bibr" rid="B85">85</xref>,<xref ref-type="bibr" rid="B86">86</xref>]. TMZ methylates guanines in DNA at the O6 position, leading to base-pair mismatch. The known O6&#x2013; methylguanine (O6&#x2013;MeG) lesion causes DNA double-strand breaks and subsequent cell death through autophagy, apoptosis, or both [<xref ref-type="bibr" rid="B87">87</xref>]. MGMT is the DNA repair enzyme that repairs the O6-MeG lesion and is induced either by chemotherapeutic agents or environmental carcinogens. Methylation of the MGMT promoter or high levels of MGMT are thought to be associated with resistance to TMZ [<xref ref-type="bibr" rid="B88">88</xref>]. Levin et al. [<xref ref-type="bibr" rid="B86">86</xref>] reported that TMZ was active in patients with progressive OGDs, and that a 1p deletion and low MGMT protein expression could contribute to a better response to TMZ treatment. For our patient, results of the MSP-PCR assays of the primary brain lesions and autopsied metastatic tissues all showed the methylated MGMT promoter. However, we regret that although several cycles of chemotherapy of TMZ were given, the patient still deteriorated rapidly and eventually succumbed. The reasons for his failure to respond favorably to TMZ chemotherapy remain to be explored.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>In summary, extracranial metastases in AO do occur, although they are very rare. Detection of molecular markers such as combined deletion of the 1p and 19q chromosomal arms, hypermethylation of the <italic>MGMT</italic> promoter, and <italic>PTEN</italic> exon mutations may help elucidate which subtypes of AO are more prone to extracranial metastases, which would benefit these patients.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient's family for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>OGD: Oligodendrogliomas; MRI: Magnetic resonance imaging; MGMT: O-6-methylguanine-DNA methyltransferase; PTEN: Phosphatase and tensin homolog; CNS: Central nervous system; AO: Anaplastic oligodendroglioma; WHO: World Health Organization; PET-CT: Positron emission tomography-computed tomography; EDTA: Ethylenediaminetetraacetic acid; IDH1: Isocitrate dehydrogenase-1; GFAP: Glial fibrillary acidic protein; EMA: Epithelial membrane antigen; MS-PCR: Methylation-specific polymerase chain reaction; PCR-SSCP: PCR single-strand conformation polymorphism; FISH: Fluorescent in situ hybridization; NCCN: National comprehensive cancer net.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interest.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>YZ and GG designed the study. GL, ZZ, SH and GC participated in designing and coordinating the study, and GL drafted the manuscript. ZZ and TJ worked together to draft the manuscript. JZ, HL, LG and HY participated in following up the patient, reviewing the relevant articles, and helped to improve the manuscript. All authors have read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgments</title>
      <p>This work is supported in part by grants from the National Natural Science Foundation of China (No. 81272776 and No. 81272419), China Postdoctoral Science Foundation (No. 20100471628 and No. 201104634), Wu Jieping Medical Foundation (320.6750.12161), Shaanxi Province Programs of Science and Technology Development (No. 2012 K 13-01-13 and 2011 K12-47), the Innovation Project 2012, and the Talents Program 2010 &amp; 2013 of Tangdu Hospital, Fourth Military Medical University. We thank all the clinicians and hospital staff for help in the collection of samples and data for this study. Additionally, we thank Prof. Dr. Qing Li, Department of Pathology, Fourth Military Medical University, and Prof. Dr. Xue-jun Yang, Department of Pathology of General Hospital, Tianjin Medical University, for sharing their experiences with primary CNS tumors.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="book">
          <name>
            <surname>Bailey</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cushing</surname>
            <given-names>P</given-names>
          </name>
          <source>A Classification of the Tumors of the Glioma Group on Histogenetic Basis with Correlated Study of Prognosis</source>
          <year>1926</year>
          <publisher-name>Philadelphia: J.B. Lippincott</publisher-name>
          <fpage>175</fpage>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Smith</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Hardman</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Earle</surname>
            <given-names>KM</given-names>
          </name>
          <article-title>Metastasizing neuroectodermal tumors of the central nervous system</article-title>
          <source>J Neurosurg</source>
          <year>1969</year>
          <volume>31</volume>
          <fpage>50</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1969.31.1.0050</pub-id>
          <pub-id pub-id-type="pmid">4307543</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Liwnicz</surname>
            <given-names>BH</given-names>
          </name>
          <name>
            <surname>Rubinstein</surname>
            <given-names>LJ</given-names>
          </name>
          <article-title>The pathways of extraneural spread in metastasizing gliomas: a report of three cases and critical review of the literature</article-title>
          <source>Hum Pathol</source>
          <year>1979</year>
          <volume>10</volume>
          <fpage>453</fpage>
          <lpage>467</lpage>
          <pub-id pub-id-type="doi">10.1016/S0046-8177(79)80051-9</pub-id>
          <pub-id pub-id-type="pmid">381159</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Han</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Yoon</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Yee</surname>
            <given-names>GT</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Sohn</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Whang</surname>
            <given-names>CJ</given-names>
          </name>
          <article-title>Extraneural metastases of anaplastic oligodendroglioma</article-title>
          <source>J Clin Neurosci</source>
          <year>2008</year>
          <volume>15</volume>
          <fpage>946</fpage>
          <lpage>949</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jocn.2006.09.013</pub-id>
          <pub-id pub-id-type="pmid">18280737</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>McLendon</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Bentley</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Parisi</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Tien</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Harrison</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Tarbell</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Billitt</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Gualtieri</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Friedman</surname>
            <given-names>HS</given-names>
          </name>
          <article-title>Malignant supratentorial glial-neuronal neoplasms: report of two cases and review of the literature</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>1997</year>
          <volume>121</volume>
          <fpage>485</fpage>
          <lpage>492</lpage>
          <pub-id pub-id-type="pmid">9167602</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tatar</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Thivat</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Planchat</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gimbergues</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gadea</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Abrial</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Durando</surname>
            <given-names>X</given-names>
          </name>
          <article-title>Temozolomide and unusual indications: review of literature</article-title>
          <source>Cancer Treat Rev</source>
          <year>2013</year>
          <volume>39</volume>
          <fpage>125</fpage>
          <lpage>135</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ctrv.2012.06.002</pub-id>
          <pub-id pub-id-type="pmid">22818211</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Louis</surname>
            <given-names>DN</given-names>
          </name>
          <name>
            <surname>Ohgaki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wiestler</surname>
            <given-names>OD</given-names>
          </name>
          <name>
            <surname>Cavenee</surname>
            <given-names>WK</given-names>
          </name>
          <name>
            <surname>Burger</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Jouvet</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Scheithauer</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Kleihues</surname>
            <given-names>P</given-names>
          </name>
          <article-title>The 2007 WHO classification of tumours of the central nervous system</article-title>
          <source>Acta Neuropathol</source>
          <year>2007</year>
          <volume>114</volume>
          <fpage>97</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="doi">10.1007/s00401-007-0243-4</pub-id>
          <pub-id pub-id-type="pmid">17618441</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Giannini</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Scheithauer</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Weaver</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Burger</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Kros</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Mork</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Graeber</surname>
            <given-names>MB</given-names>
          </name>
          <name>
            <surname>Bauserman</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Buckner</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Burton</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Riepe</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Tazelaar</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Nascimento</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Crotty</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Keeney</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Pemicone</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Altermatt</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>2001</year>
          <volume>60</volume>
          <fpage>248</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="pmid">11245209</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Stupp</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hegi</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Mason</surname>
            <given-names>WP</given-names>
          </name>
          <name>
            <surname>van den Bent</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Taphoorn</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Janzer</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Ludwin</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Allgeier</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fisher</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Belanger</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hau</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Brandes</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Gijtenbeek</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Marosi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vecht</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Mokhtari</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wesseling</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Villa</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Eisenhauer</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gorlia</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Weller</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lacombe</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cairncross</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Mirimanoff</surname>
            <given-names>RO</given-names>
          </name>
          <article-title>European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group: effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial</article-title>
          <source>Lancet Oncol</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>459</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="doi">10.1016/S1470-2045(09)70025-7</pub-id>
          <pub-id pub-id-type="pmid">19269895</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hegi</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Herman</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Stupp</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wick</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Weller</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Gilbert</surname>
            <given-names>MR</given-names>
          </name>
          <article-title>Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity</article-title>
          <source>J Clin Oncol</source>
          <year>2008</year>
          <volume>26</volume>
          <fpage>4189</fpage>
          <lpage>4199</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2007.11.5964</pub-id>
          <pub-id pub-id-type="pmid">18757334</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Reineke</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Jenni</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Abdou</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Frigerio</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zubler</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Moch</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tinguely</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Ultrasonic decalcification offers new perspectives for rapid FISH, DNA, and RT-PCR analysis in bone marrow trephines</article-title>
          <source>Am J Surg Pathol</source>
          <year>2006</year>
          <volume>30</volume>
          <fpage>892</fpage>
          <lpage>896</lpage>
          <pub-id pub-id-type="doi">10.1097/01.pas.0000213282.20166.13</pub-id>
          <pub-id pub-id-type="pmid">16819333</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mehdi</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Alam</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Batra</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rizvi</surname>
            <given-names>MMA</given-names>
          </name>
          <article-title>Allelic loss at 6q25&#x2013;27, the Parkin tumor suppressor gene locus in cervical carcinoma</article-title>
          <source>Med Oncol</source>
          <year>2011</year>
          <volume>28</volume>
          <fpage>1520</fpage>
          <lpage>1526</lpage>
          <pub-id pub-id-type="doi">10.1007/s12032-010-9633-x</pub-id>
          <pub-id pub-id-type="pmid">20652448</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="book">
          <name>
            <surname>Sambrook</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Russell</surname>
            <given-names>DW</given-names>
          </name>
          <source>Molecular cloning: A laboratory manual</source>
          <year>2001</year>
          <edition>3</edition>
          <publisher-name>Cold Spring Harbor Lab. Press: Cold Spring Harbor</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dong</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Pang</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Poon</surname>
            <given-names>WS</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>HK</given-names>
          </name>
          <article-title>Identification of two contiguous minimally deleted regions on chromosome 1p36.31-p36.32 in oligodendroglial tumors</article-title>
          <source>Br J Cancer</source>
          <year>2004</year>
          <volume>91</volume>
          <fpage>1105</fpage>
          <lpage>1111</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.bjc.6602093</pub-id>
          <pub-id pub-id-type="pmid">15475940</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hegi</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Diserens</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Gorlia</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hamou</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>de Tribolet</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Weller</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kros</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Hainfellner</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Mason</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Mariani</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bromberg</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Hau</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mirimanoff</surname>
            <given-names>RO</given-names>
          </name>
          <name>
            <surname>Cairncross</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Janzer</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Stupp</surname>
            <given-names>R</given-names>
          </name>
          <article-title>MGMT gene silencing and benefit from temozolomide in glioblastoma</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>352</volume>
          <fpage>997</fpage>
          <lpage>1003</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa043331</pub-id>
          <pub-id pub-id-type="pmid">15758010</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Eng</surname>
            <given-names>C</given-names>
          </name>
          <article-title>PTEN: one gene, many syndromes</article-title>
          <source>Hum Mutat</source>
          <year>2003</year>
          <volume>22</volume>
          <fpage>183</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="doi">10.1002/humu.10257</pub-id>
          <pub-id pub-id-type="pmid">12938083</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zheng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Murai</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Nomoto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tsuneyama</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Takano</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings</article-title>
          <source>Appl Immunohistochem Mol Morphol</source>
          <year>2007</year>
          <volume>15</volume>
          <fpage>432</fpage>
          <lpage>440</lpage>
          <pub-id pub-id-type="doi">10.1097/01.pai.0000213127.96590.2d</pub-id>
          <pub-id pub-id-type="pmid">18091387</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="other">
          <name>
            <surname>Ali</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Saluja</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Hajela</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mishra</surname>
            <given-names>PK</given-names>
          </name>
          <name>
            <surname>Rizvi</surname>
            <given-names>MA</given-names>
          </name>
          <article-title>Mutational and expressional analyses of PTEN gene in colorectal cancer from Northern India</article-title>
          <source>Mol Carcinog</source>
          <year>2013</year>
          <comment>10.1002/mc.22001. [Epub ahead of print]</comment>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rizvi</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Shabbir</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Ali</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mehdi</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Batra</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mandal</surname>
            <given-names>AK</given-names>
          </name>
          <article-title>Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population</article-title>
          <source>J Cancer Res Clin Oncol</source>
          <year>2011</year>
          <volume>137</volume>
          <fpage>1255</fpage>
          <lpage>1262</lpage>
          <pub-id pub-id-type="doi">10.1007/s00432-011-0994-0</pub-id>
          <pub-id pub-id-type="pmid">21698421</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Guo</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>XF</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>SF</given-names>
          </name>
          <article-title>PCR&#x2013;SSCP-DNA sequencing method in detecting PTEN gene mutation and its significance in human gastric cancer</article-title>
          <source>World J Gastroenterol</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>3804</fpage>
          <lpage>3811</lpage>
          <pub-id pub-id-type="doi">10.3748/wjg.14.3804</pub-id>
          <pub-id pub-id-type="pmid">18609703</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Garner</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Morcos</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Bari</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Extradural cord compression due to metastatic oligodendroglioma</article-title>
          <source>J Neurooncol</source>
          <year>2002</year>
          <volume>58</volume>
          <fpage>71</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1015805329661</pub-id>
          <pub-id pub-id-type="pmid">12160143</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Subramanian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Piggott</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shieff</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bradford</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Metastasis to and from the central nervous system: the &#x2018;relatively protected site&#x2019;</article-title>
          <source>Lancet Oncol</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>498</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="doi">10.1016/S1470-2045(02)00819-7</pub-id>
          <pub-id pub-id-type="pmid">12147436</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Al-Ali</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Hendon</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Liepman</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Wisniewski</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Krinock</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Beckman</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Oligodendroglioma metastatic to bone marrow</article-title>
          <source>AJNR Am J Neuroradiol</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>2410</fpage>
          <lpage>2414</lpage>
          <pub-id pub-id-type="pmid">16219856</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fayeye</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Sankaran</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Sherlala</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Choksey</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Oligodendroglioma presenting with intradural spinal metastases: an unusual cause of cauda equine syndrome</article-title>
          <source>J Clin Neurosci</source>
          <year>2010</year>
          <volume>17</volume>
          <fpage>265</fpage>
          <lpage>267</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jocn.2009.05.029</pub-id>
          <pub-id pub-id-type="pmid">20042338</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shaw</surname>
            <given-names>EG</given-names>
          </name>
          <name>
            <surname>Scheithauer</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>O&#x2019;Fallon</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Tazelaar</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>DH</given-names>
          </name>
          <article-title>Oligodendrogliomas: the Mayo Clinic experience</article-title>
          <source>J Neurosurg</source>
          <year>1992</year>
          <volume>76</volume>
          <fpage>428</fpage>
          <lpage>434</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1992.76.3.0428</pub-id>
          <pub-id pub-id-type="pmid">1738022</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>James</surname>
            <given-names>TGI</given-names>
          </name>
          <name>
            <surname>Pagel</surname>
            <given-names>W</given-names>
          </name>
          <article-title>Oligodenroglioma with extracranial metastases</article-title>
          <source>Br J Surg</source>
          <year>1951</year>
          <volume>39</volume>
          <fpage>56</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1002/bjs.18003915312</pub-id>
          <pub-id pub-id-type="pmid">14858828</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Spataro</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sacks</surname>
            <given-names>O</given-names>
          </name>
          <article-title>Oligodendroglioma with remote metastases. Case report.</article-title>
          <source>J Neurosurg</source>
          <year>1968</year>
          <volume>28</volume>
          <fpage>373</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1968.28.4.0373</pub-id>
          <pub-id pub-id-type="pmid">5643931</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Jellinger</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Minauf</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Salzer-Kuntschik</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Oligodendroglioma with extraneural metastases</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1969</year>
          <volume>32</volume>
          <fpage>249</fpage>
          <lpage>253</lpage>
          <pub-id pub-id-type="doi">10.1136/jnnp.32.3.249</pub-id>
          <pub-id pub-id-type="pmid">5795118</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Schuster</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jellinger</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gund</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Regele</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Extracranial metastases of anaplastic cerebral gliomas</article-title>
          <source>Acta Neurochir (Wien)</source>
          <year>1976</year>
          <volume>35</volume>
          <fpage>247</fpage>
          <lpage>259</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01406121</pub-id>
          <pub-id pub-id-type="pmid">998355</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="book">
          <name>
            <surname>Kernohan</surname>
            <given-names>JW</given-names>
          </name>
          <article-title>Oligodendrogliomas</article-title>
          <source>Minckler J (ed) Pathology of the nervous system</source>
          <year>1971</year>
          <edition>Vol 2</edition>
          <publisher-name>New York: McGraw-Hill Co</publisher-name>
          <comment>1993&#x2013;2007</comment>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Eade</surname>
            <given-names>OE</given-names>
          </name>
          <name>
            <surname>Urich</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Metastasising gliomas in young subjects</article-title>
          <source>J Pathol</source>
          <year>1971</year>
          <volume>103</volume>
          <fpage>245</fpage>
          <lpage>256</lpage>
          <pub-id pub-id-type="doi">10.1002/path.1711030407</pub-id>
          <pub-id pub-id-type="pmid">5563877</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cappalaere</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Clay</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Adenis</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Demaille</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Laine</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Les metastases des tumors cerebrales primitives en dehors du nevraxe: a propos de trios observations</article-title>
          <source>Bull Cancer (Paris)</source>
          <year>1972</year>
          <volume>59</volume>
          <fpage>235</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="pmid">4667738</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Brander</surname>
            <given-names>WL</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>DR</given-names>
          </name>
          <article-title>Extracranial metastases from a glioma in the absence of surgical intervention</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1975</year>
          <volume>38</volume>
          <fpage>1133</fpage>
          <lpage>1135</lpage>
          <pub-id pub-id-type="doi">10.1136/jnnp.38.11.1133</pub-id>
          <pub-id pub-id-type="pmid">1206423</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kummer</surname>
            <given-names>RV</given-names>
          </name>
          <name>
            <surname>Volk</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dorndorf</surname>
            <given-names>W</given-names>
          </name>
          <article-title>Extraneural metastasierendes oligodendrogliom</article-title>
          <source>Arch Psychiatr Nervenkr</source>
          <year>1969</year>
          <volume>223</volume>
          <fpage>287</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="pmid">901157</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chin</surname>
            <given-names>HW</given-names>
          </name>
          <name>
            <surname>Hazel</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>TH</given-names>
          </name>
          <name>
            <surname>Webster</surname>
            <given-names>JH</given-names>
          </name>
          <article-title>Oligodendrogliomas. I. A clinical study of cerebral oligodendrogliomas</article-title>
          <source>Cancer</source>
          <year>1980</year>
          <volume>45</volume>
          <fpage>1458</fpage>
          <lpage>1466</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19800315)45:6&lt;1458::AID-CNCR2820450627&gt;3.0.CO;2-0</pub-id>
          <pub-id pub-id-type="pmid">6766802</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ordonez</surname>
            <given-names>NG</given-names>
          </name>
          <name>
            <surname>Ayala</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Leavens</surname>
            <given-names>ME</given-names>
          </name>
          <article-title>Extracranial metastases of oligodenroglioma: report of a case and review of the literature</article-title>
          <source>Neurosurgery</source>
          <year>1981</year>
          <volume>8</volume>
          <fpage>391</fpage>
          <lpage>395</lpage>
          <comment>comments 395&#x2013;396</comment>
          <pub-id pub-id-type="doi">10.1227/00006123-198103000-00012</pub-id>
          <pub-id pub-id-type="pmid">7242888</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nakamura</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Watanabe</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nomura</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakajima</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Diffuse bone marrow metastasis of an anaplastic oligodendroglioma</article-title>
          <source>No Shinkei Geka</source>
          <year>1985</year>
          <volume>13</volume>
          <fpage>903</fpage>
          <lpage>909</lpage>
          <pub-id pub-id-type="pmid">4058667</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Newman</surname>
            <given-names>HFV</given-names>
          </name>
          <name>
            <surname>Howard</surname>
            <given-names>GCV</given-names>
          </name>
          <name>
            <surname>Reid</surname>
            <given-names>PM</given-names>
          </name>
          <article-title>Metastatic oligodendroglioma presenting as a leukoerythroblastic anaemia</article-title>
          <source>Eur J Surg Onc</source>
          <year>1985</year>
          <volume>11</volume>
          <fpage>287</fpage>
          <lpage>288</lpage>
        </mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Macdonald</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>O&#x2019;Brien</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Gilbert</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Cairncross</surname>
            <given-names>JG</given-names>
          </name>
          <article-title>Metastatic anaplastic oligodendroglioma</article-title>
          <source>Neurology</source>
          <year>1989</year>
          <volume>39</volume>
          <fpage>1593</fpage>
          <lpage>1596</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.39.12.1593</pub-id>
          <pub-id pub-id-type="pmid">2685656</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rolski</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rzepecki</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Ka&#x142;uza</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zeme&#x142;ka</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zuchowska-Vogelgesang</surname>
            <given-names>B</given-names>
          </name>
          <article-title>A rare case of dissemination of anaplastic oligodendroma outside the central nervous system</article-title>
          <source>Neurol Neurochir Pol</source>
          <year>1993</year>
          <volume>27</volume>
          <fpage>93</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">8502365</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Steininger</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>von Streitberg</surname>
            <given-names>U</given-names>
          </name>
          <article-title>Oligodendroglioma with cervical lymph node metastasis</article-title>
          <source>Pathologe</source>
          <year>1993</year>
          <volume>14</volume>
          <fpage>386</fpage>
          <lpage>390</lpage>
          <pub-id pub-id-type="pmid">8121896</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gerrard</surname>
            <given-names>GE</given-names>
          </name>
          <name>
            <surname>Bond</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Jack</surname>
            <given-names>AS</given-names>
          </name>
          <article-title>Bone marrow infiltration by a parietal lobe grade III oligodendroglioma</article-title>
          <source>Clin Oncol (R Coll Radiol)</source>
          <year>1995</year>
          <volume>7</volume>
          <fpage>321</fpage>
          <lpage>322</lpage>
          <pub-id pub-id-type="doi">10.1016/S0936-6555(05)80543-6</pub-id>
          <pub-id pub-id-type="pmid">8580060</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Schr&#xF6;der</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lorenzen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ostertag</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ortmann</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hansmann</surname>
            <given-names>ML</given-names>
          </name>
          <article-title>Extraneural metastasis of brain and spinal cord tumors. Report of 2 cases</article-title>
          <source>Pathologe</source>
          <year>1995</year>
          <volume>16</volume>
          <fpage>223</fpage>
          <lpage>229</lpage>
          <pub-id pub-id-type="doi">10.1007/s002920050095</pub-id>
          <pub-id pub-id-type="pmid">7792275</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Monzani</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Rovellini</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Masini</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Cappricci</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Miserocchi</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Metastatic oligodendroglioma</article-title>
          <source>Case report. J Neurol Sci</source>
          <year>1996</year>
          <volume>40</volume>
          <fpage>239</fpage>
          <lpage>241</lpage>
        </mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dawson</surname>
            <given-names>TP</given-names>
          </name>
          <article-title>Case report. Pancytopenia from a disseminated anaplastic oligodendroglioma</article-title>
          <source>Neuropathol App Neurobiol</source>
          <year>1997</year>
          <volume>23</volume>
          <fpage>516</fpage>
          <lpage>520</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2990.1997.tb01330.x</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Finsterer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Breiteneder</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mueller</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Wogritsch</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vesely</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kleinert</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pendl</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mamoli</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Pleural and bone marrow metastasis from supratentorial oligoastrocytoma grade III</article-title>
          <source>Oncology</source>
          <year>1998</year>
          <volume>55</volume>
          <fpage>345</fpage>
          <lpage>348</lpage>
          <pub-id pub-id-type="doi">10.1159/000011875</pub-id>
          <pub-id pub-id-type="pmid">9663425</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Anand</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Jain</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Ghosal</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Agarwal</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>MC</given-names>
          </name>
          <article-title>Metastatic anaplastic oligodendroglioma simulating acute leukaemia</article-title>
          <source>Acta Cytol</source>
          <year>2003</year>
          <volume>47</volume>
          <fpage>467</fpage>
          <lpage>469</lpage>
          <pub-id pub-id-type="doi">10.1159/000326552</pub-id>
          <pub-id pub-id-type="pmid">12789933</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Giordana</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Gasverde</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Balteri</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Bone metastasis of oligodendrogliomas: clinical and molecular genetic study</article-title>
          <source>Neuro Oncol</source>
          <year>2002</year>
          <volume>4</volume>
          <fpage>38e</fpage>
        </mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sharma</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Agarwal</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Anand</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Agarwal</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Raina</surname>
            <given-names>V</given-names>
          </name>
          <article-title>Bone marrow metastasis in anaplastic oligodendroglioma</article-title>
          <source>Int J Clin Pract</source>
          <year>2003</year>
          <volume>57</volume>
          <fpage>351</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="pmid">12800473</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Choon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Roepke</surname>
            <given-names>JE</given-names>
          </name>
          <article-title>Importance of immunohistochemichal staining in metastatic anaplastic oligodendroglioma</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2004</year>
          <volume>128</volume>
          <fpage>489</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="pmid">15043478</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Morrison</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Bilbao</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Perry</surname>
            <given-names>JR</given-names>
          </name>
          <article-title>Bony metastases of anaplastic oligodendroglioma respond to temozolomide</article-title>
          <source>Can J Neurol Sci</source>
          <year>2004</year>
          <volume>31</volume>
          <fpage>102</fpage>
          <lpage>108</lpage>
          <pub-id pub-id-type="pmid">15038479</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Murphy</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Kulesza</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hatanpaa</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Olivi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tufaro</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Erozan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Westra</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>Burger</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Berg</surname>
            <given-names>KD</given-names>
          </name>
          <article-title>Molecular diagnosis of metastasizing oligodendroglioma: a case report</article-title>
          <source>J Mol Diagn</source>
          <year>2004</year>
          <volume>6</volume>
          <fpage>52</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="doi">10.1016/S1525-1578(10)60491-6</pub-id>
          <pub-id pub-id-type="pmid">14736827</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Merrell</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Nabors</surname>
            <given-names>LB</given-names>
          </name>
          <name>
            <surname>Perry</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Palmer</surname>
            <given-names>CA</given-names>
          </name>
          <article-title>1p/19q chromosome deletions in metastatic oligodendroglioma</article-title>
          <source>J Neurooncol</source>
          <year>2006</year>
          <volume>80</volume>
          <fpage>203</fpage>
          <lpage>207</lpage>
          <pub-id pub-id-type="doi">10.1007/s11060-006-9179-0</pub-id>
          <pub-id pub-id-type="pmid">16710746</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lee</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>ET</given-names>
          </name>
          <name>
            <surname>Yokoo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>YH</given-names>
          </name>
          <name>
            <surname>Tsai</surname>
            <given-names>MD</given-names>
          </name>
          <article-title>Cytologic diagnosis of a metastatic oligodendroglioma in a pleural effusion. A case report.</article-title>
          <source>Acta Cytol</source>
          <year>2006</year>
          <volume>50</volume>
          <fpage>542</fpage>
          <lpage>544</lpage>
          <pub-id pub-id-type="doi">10.1159/000326011</pub-id>
          <pub-id pub-id-type="pmid">17017442</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bruggers</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>White</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Z</given-names>
          </name>
          <article-title>Extracranial relapse of an anaplastic oligodendroglioma in an adolescent: case report and review of the literature</article-title>
          <source>J Pediatr Hematol Oncol</source>
          <year>2007</year>
          <volume>29</volume>
          <fpage>319</fpage>
          <lpage>322</lpage>
          <pub-id pub-id-type="doi">10.1097/MPH.0b013e318054756e</pub-id>
          <pub-id pub-id-type="pmid">17483710</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Uzuka</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kakita</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Inenaga</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Frontal anaplastic oligodendroglioma showing multi-organ metastases after a long clinical course. Case report.</article-title>
          <source>Neurol Med Chir (Tokyo)</source>
          <year>2007</year>
          <volume>47</volume>
          <fpage>174</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="doi">10.2176/nmc.47.174</pub-id>
          <pub-id pub-id-type="pmid">17457022</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zustovich</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Della Puppa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Scienza</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Anselmi</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Furlan</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cartei</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Metastatic oligodendrogliomas: a review of the literature and case report</article-title>
          <source>Acta Neurochir (Wien)</source>
          <year>2008</year>
          <volume>150</volume>
          <fpage>699</fpage>
          <lpage>702</lpage>
          <comment>discussion 702&#x2013;703</comment>
          <pub-id pub-id-type="doi">10.1007/s00701-008-1507-z</pub-id>
          <pub-id pub-id-type="pmid">18548193</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Volavsek</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lamovec</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Popovi&#x107;</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Extraneural metastases of anaplastic oligodendroglial tumors</article-title>
          <source>Pathol Res Pract</source>
          <year>2009</year>
          <volume>205</volume>
          <fpage>502</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="doi">10.1016/j.prp.2008.11.003</pub-id>
          <pub-id pub-id-type="pmid">19410385</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Noshita</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Mashiyama</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fukawa</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Asano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Watanabe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tominaga</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Extracranial metastasis of anaplastic oligodendroglioma with 1p19q loss of heterozygosity&#x2013;case report</article-title>
          <source>Neurol Med Chir (Tokyo)</source>
          <year>2010</year>
          <volume>50</volume>
          <fpage>161</fpage>
          <lpage>164</lpage>
          <pub-id pub-id-type="doi">10.2176/nmc.50.161</pub-id>
          <pub-id pub-id-type="pmid">20185886</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Oshiro</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Komatsu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Tsugu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nabeshima</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Abe</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ohkawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>T</given-names>
          </name>
          <article-title>A case of intramedullary cervical metastasis from cerebellar anaplastic oligodendroglioma without typical MR appearance for CSF dissemination</article-title>
          <source>No Shinkei Geka</source>
          <year>2010</year>
          <volume>38</volume>
          <fpage>279</fpage>
          <lpage>285</lpage>
          <pub-id pub-id-type="pmid">20229774</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Krijnen</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Fleischeur</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>van Berkel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Westenend</surname>
            <given-names>PJ</given-names>
          </name>
          <article-title>Metastatic oligodendroglioma: a case report and incidence in The Netherlands</article-title>
          <source>Clin Neuropathol</source>
          <year>2010</year>
          <volume>29</volume>
          <fpage>141</fpage>
          <lpage>146</lpage>
          <pub-id pub-id-type="doi">10.5414/NPP29141</pub-id>
          <pub-id pub-id-type="pmid">20423687</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kural</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Pusat</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sent&#xFC;rk</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Se&#xE7;er</surname>
            <given-names>H&#x130;</given-names>
          </name>
          <name>
            <surname>Izci</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Extracranial metastases of anaplastic oligodendroglioma</article-title>
          <source>J Clin Neurosci</source>
          <year>2011</year>
          <volume>18</volume>
          <fpage>136</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jocn.2010.05.028</pub-id>
          <pub-id pub-id-type="pmid">20888774</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Qu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Tao</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Extracranial skeletal metastasis in anaplastic oligodendroglioma: case report and review of the literature</article-title>
          <source>J Int Med Res</source>
          <year>2011</year>
          <volume>39</volume>
          <fpage>960</fpage>
          <lpage>967</lpage>
          <pub-id pub-id-type="doi">10.1177/147323001103900331</pub-id>
          <pub-id pub-id-type="pmid">21819730</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cordiano</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Miserocchi</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Storti</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Bone marrow metastases from anaplastic oligodendroglioma presenting with pancytopenia and hypogammaglobulinemia: a case report</article-title>
          <source>Tumori</source>
          <year>2011</year>
          <volume>97</volume>
          <fpage>808</fpage>
          <lpage>811</lpage>
          <pub-id pub-id-type="pmid">22322851</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B65">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Can</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Akpolat</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Meydan</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>&#xDC;ner</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kandemir</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>S&#xF6;ylemezo&#x11F;lu</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Fine-needle aspiration cytology of metastatic oligodendroglioma: case report and literature review</article-title>
          <source>Acta Cytol</source>
          <year>2012</year>
          <volume>56</volume>
          <fpage>97</fpage>
          <lpage>103</lpage>
          <pub-id pub-id-type="doi">10.1159/000331769</pub-id>
          <pub-id pub-id-type="pmid">22236753</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B66">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Alacacioglu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Unal</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Canpolat</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yurt</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Oztekin</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Coskun</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Karatas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Postaci</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sop</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Breast metastasis of anaplastic oligodendroglioma: a case report</article-title>
          <source>Tumori</source>
          <year>2012</year>
          <volume>98</volume>
          <fpage>162e</fpage>
          <lpage>164e</lpage>
          <pub-id pub-id-type="pmid">22495718</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B67">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Greene</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cadoo</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ti</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>O&#x2019;Donnell</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Allcutt</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Farrell</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Grogan</surname>
            <given-names>L</given-names>
          </name>
          <article-title>1p19q co-deleted oligodendroglioma metastatic to bone</article-title>
          <source>Clin Neuropathol</source>
          <year>2013</year>
          <volume>32</volume>
          <fpage>139</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="doi">10.5414/NP300507</pub-id>
          <pub-id pub-id-type="pmid">23073167</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B68">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gyepes</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>D&#x2019; angio</surname>
            <given-names>GJ</given-names>
          </name>
          <article-title>Extracranial metastases from central nervous system tumors in children and adolescents</article-title>
          <source>Radiology</source>
          <year>1966</year>
          <volume>87</volume>
          <fpage>55</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">4287332</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B69">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Carlsen</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Tietze</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lassen</surname>
            <given-names>YA</given-names>
          </name>
          <name>
            <surname>Rosendal</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Paraplegia due to drop metastases from anaplastic oligodendroglioma</article-title>
          <source>Br J Neurosurg</source>
          <year>2012</year>
          <volume>26</volume>
          <fpage>94</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="doi">10.3109/02688697.2011.578767</pub-id>
          <pub-id pub-id-type="pmid">21591854</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B70">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Schweitzer</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vince</surname>
            <given-names>GH</given-names>
          </name>
          <name>
            <surname>Herbold</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Roosen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tonn</surname>
            <given-names>JC</given-names>
          </name>
          <article-title>Extraneural metastases of primary brain tumors</article-title>
          <source>J Neurooncol</source>
          <year>2001</year>
          <volume>53</volume>
          <fpage>107</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1012245115209</pub-id>
          <pub-id pub-id-type="pmid">11716064</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B71">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoffman</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Duffner</surname>
            <given-names>PK</given-names>
          </name>
          <article-title>Extraneural metastases of central nervous system tumors</article-title>
          <source>Cancer</source>
          <year>1985</year>
          <volume>56</volume>
          <fpage>1778</fpage>
          <lpage>1782</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19851001)56:7+&lt;1778::AID-CNCR2820561309&gt;3.0.CO;2-I</pub-id>
          <pub-id pub-id-type="pmid">4027909</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B72">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mechtler</surname>
            <given-names>LL</given-names>
          </name>
          <name>
            <surname>Nandigam</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Spinal cord tumors: new views and future directions</article-title>
          <source>Neurol Clin</source>
          <year>2013</year>
          <volume>31</volume>
          <fpage>241</fpage>
          <lpage>268</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ncl.2012.09.011</pub-id>
          <pub-id pub-id-type="pmid">23186903</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B73">
        <mixed-citation publication-type="other">
          <collab>NCCN Clinical Practice Guidelines in Oncology</collab>
          <source>Central Nervous System Cancers. Version1</source>
          <year>2013</year>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/pdf/cns.pdf">http://www.nccn.org/professionals/physician_ gls/pdf/cns.pdf</ext-link>
          </comment>
        </mixed-citation>
      </ref>
      <ref id="B74">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cairncross</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Ueki</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zlatescu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lisle</surname>
            <given-names>DK</given-names>
          </name>
          <name>
            <surname>Finkelstein</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Hammond</surname>
            <given-names>RR</given-names>
          </name>
          <name>
            <surname>Silver</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Stark</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Macdonald</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Ino</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ramsay</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Louis</surname>
            <given-names>DN</given-names>
          </name>
          <article-title>Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendroglioma</article-title>
          <source>J Natl Cancer Inst</source>
          <year>1998</year>
          <volume>90</volume>
          <fpage>1473</fpage>
          <lpage>1479</lpage>
          <pub-id pub-id-type="doi">10.1093/jnci/90.19.1473</pub-id>
          <pub-id pub-id-type="pmid">9776413</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B75">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Smith</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Perry</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Borell</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>O&#x2019;Fallon</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hosek</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Kimmel</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Yates</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Burger</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Scheithauer</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>RB</given-names>
          </name>
          <article-title>Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas</article-title>
          <source>J Clin Oncol</source>
          <year>2000</year>
          <volume>18</volume>
          <fpage>636</fpage>
          <lpage>645</lpage>
          <pub-id pub-id-type="pmid">10653879</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B76">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Davis</surname>
            <given-names>FG</given-names>
          </name>
          <name>
            <surname>McCarthy</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Freels</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kupelian</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Bondy</surname>
            <given-names>ML</given-names>
          </name>
          <article-title>The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data</article-title>
          <source>Cancer</source>
          <year>1999</year>
          <volume>85</volume>
          <fpage>485</fpage>
          <lpage>491</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19990115)85:2&lt;485::AID-CNCR29&gt;3.0.CO;2-L</pub-id>
          <pub-id pub-id-type="pmid">10023719</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B77">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Scott</surname>
            <given-names>CB</given-names>
          </name>
          <name>
            <surname>Scarantino</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Urtasun</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Movsas</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>CU</given-names>
          </name>
          <name>
            <surname>Simpson</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Fischbach</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Curran</surname>
            <given-names>WJ</given-names>
            <suffix>Jr</suffix>
          </name>
          <article-title>Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90&#x2013;06</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>1998</year>
          <volume>40</volume>
          <fpage>51</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.1016/S0360-3016(97)00485-9</pub-id>
          <pub-id pub-id-type="pmid">9422557</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B78">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Broderick</surname>
            <given-names>DK</given-names>
          </name>
          <name>
            <surname>Di</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Parrett</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Samuels</surname>
            <given-names>YR</given-names>
          </name>
          <name>
            <surname>Cummins</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>McLendon</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Fults</surname>
            <given-names>DW</given-names>
          </name>
          <name>
            <surname>Velculescu</surname>
            <given-names>VE</given-names>
          </name>
          <name>
            <surname>Bigner</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas</article-title>
          <source>Cancer Res</source>
          <year>2004</year>
          <volume>64</volume>
          <fpage>5048</fpage>
          <lpage>5050</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-1170</pub-id>
          <pub-id pub-id-type="pmid">15289301</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B79">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ino</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Betensky</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Zlatescu</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Sasaki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Macdonald</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Stemmer-Rachamimov</surname>
            <given-names>AO</given-names>
          </name>
          <name>
            <surname>Ramsay</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Cairncross</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Louis</surname>
            <given-names>DN</given-names>
          </name>
          <article-title>Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis</article-title>
          <source>Clin Cancer Res</source>
          <year>2001</year>
          <volume>7</volume>
          <fpage>839</fpage>
          <lpage>845</lpage>
          <pub-id pub-id-type="pmid">11309331</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B80">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shao</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Nilsson-Ehle</surname>
            <given-names>PXN</given-names>
          </name>
          <article-title>Mutations of PTEN gene in gliomas correlate to tumor differentiation and short-term survival rate</article-title>
          <source>Anticancer Res</source>
          <year>2010</year>
          <volume>30</volume>
          <fpage>981</fpage>
          <lpage>985</lpage>
          <pub-id pub-id-type="pmid">20393024</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B81">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wang</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>FM</given-names>
          </name>
          <name>
            <surname>Hsieh</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Hou</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Hsieh</surname>
            <given-names>JS</given-names>
          </name>
          <article-title>Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas</article-title>
          <source>Virchows Arch</source>
          <year>2003</year>
          <volume>442</volume>
          <fpage>437</fpage>
          <lpage>443</lpage>
          <pub-id pub-id-type="pmid">12695913</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B82">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tate</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mitsuya</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Mutation of the PTEN gene in a human hepatic angiosarcoma</article-title>
          <source>Cancer Genet Cytogenet</source>
          <year>2007</year>
          <volume>178</volume>
          <fpage>160</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cancergencyto.2007.07.017</pub-id>
          <pub-id pub-id-type="pmid">17954274</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B83">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rizvi</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Ali</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mehdi</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Saluja</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Mishra</surname>
            <given-names>PK</given-names>
          </name>
          <article-title>Association of epigenetic alteration in PTEN gene with colorectal cancer progression among Indian population</article-title>
          <source>Int J Colorectal Dis</source>
          <year>2013</year>
          <volume>28</volume>
          <fpage>283</fpage>
          <lpage>284</lpage>
          <pub-id pub-id-type="doi">10.1007/s00384-012-1482-y</pub-id>
          <pub-id pub-id-type="pmid">22552802</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B84">
        <mixed-citation publication-type="journal">
          <name>
            <surname>van den Bent</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Taphoorn</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Brandes</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Menten</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Stupp</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Frenay</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chinot</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Kros</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>van der Rijt</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Vecht</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Allgeier</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gorlia</surname>
            <given-names>T</given-names>
          </name>
          <article-title>European Organization for Research and Treatment of Cancer Brain Tumor Group: Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971</article-title>
          <source>J Clin Oncol</source>
          <year>2003</year>
          <volume>21</volume>
          <fpage>2525</fpage>
          <lpage>2528</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2003.12.015</pub-id>
          <pub-id pub-id-type="pmid">12829671</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B85">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoang-Xuan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Capelle</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kujas</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Taillibert</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Duffau</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lejeune</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Polivka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Crini&#xE8;re</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Marie</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Mokhtari</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Carpentier</surname>
            <given-names>AF</given-names>
          </name>
          <name>
            <surname>Laigle</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Simon</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Cornu</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bro&#xEB;t</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Sanson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Delattre</surname>
            <given-names>JY</given-names>
          </name>
          <article-title>Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions</article-title>
          <source>J Clin Oncol</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>3133</fpage>
          <lpage>3138</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2004.10.169</pub-id>
          <pub-id pub-id-type="pmid">15284265</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B86">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Levin</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lavon</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Zelikovitsh</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Fuchs</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bokstein</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Fellig</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Siegal</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6- methylguanine DNA methyltransferase protein expression</article-title>
          <source>Cancer</source>
          <year>2006</year>
          <volume>106</volume>
          <fpage>1759</fpage>
          <lpage>1765</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.21809</pub-id>
          <pub-id pub-id-type="pmid">16541434</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B87">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ziegler</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Kung</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Kieran</surname>
            <given-names>MW</given-names>
          </name>
          <article-title>Antiapoptosis mechanisms in malignant gliomas</article-title>
          <source>J Clin Oncol</source>
          <year>2008</year>
          <volume>26</volume>
          <fpage>493</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2007.13.9717</pub-id>
          <pub-id pub-id-type="pmid">18202424</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B88">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kesari</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schiff</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Drappatz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>LaFrankie</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Doherty</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Macklin</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Muzikansky</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Santagata</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ligon</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Norden</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Ciampa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bradshaw</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Levy</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Radakovic</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ramakrishna</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Black</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Wen</surname>
            <given-names>PY</given-names>
          </name>
          <article-title>Phase II study of protracted daily temozolomide for lowgrade gliomas in adults</article-title>
          <source>Clin Cancer Res</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>330</fpage>
          <lpage>337</lpage>
          <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-08-0888</pub-id>
          <pub-id pub-id-type="pmid">19118062</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
